KR20200103618A - Patch and its manufacturing method - Google Patents
Patch and its manufacturing method Download PDFInfo
- Publication number
- KR20200103618A KR20200103618A KR1020207000531A KR20207000531A KR20200103618A KR 20200103618 A KR20200103618 A KR 20200103618A KR 1020207000531 A KR1020207000531 A KR 1020207000531A KR 20207000531 A KR20207000531 A KR 20207000531A KR 20200103618 A KR20200103618 A KR 20200103618A
- Authority
- KR
- South Korea
- Prior art keywords
- mass
- component
- adhesive layer
- sensitive adhesive
- pressure
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 23
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims abstract description 79
- 239000010410 layer Substances 0.000 claims abstract description 66
- 150000003839 salts Chemical class 0.000 claims abstract description 21
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 20
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 18
- 239000004584 polyacrylic acid Substances 0.000 claims abstract description 18
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 18
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 17
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 17
- 239000007864 aqueous solution Substances 0.000 claims abstract description 16
- 229920002678 cellulose Polymers 0.000 claims abstract description 13
- 239000001913 cellulose Substances 0.000 claims abstract description 13
- 229910052751 metal Inorganic materials 0.000 claims abstract description 7
- 239000002184 metal Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000012790 adhesive layer Substances 0.000 abstract description 12
- -1 amine salts Chemical class 0.000 description 40
- 238000009940 knitting Methods 0.000 description 25
- 238000002156 mixing Methods 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 239000006185 dispersion Substances 0.000 description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000004744 fabric Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000004745 nonwoven fabric Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 5
- OVBJJZOQPCKUOR-UHFFFAOYSA-L EDTA disodium salt dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O OVBJJZOQPCKUOR-UHFFFAOYSA-L 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229940037001 sodium edetate Drugs 0.000 description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 4
- SCCDQYPEOIRVGX-UHFFFAOYSA-N Acetyleugenol Chemical compound COC1=CC(CC=C)=CC=C1OC(C)=O SCCDQYPEOIRVGX-UHFFFAOYSA-N 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 241001092387 Spiraea Species 0.000 description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical class COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 4
- 229960000905 indomethacin Drugs 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 238000006386 neutralization reaction Methods 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- 235000019983 sodium metaphosphate Nutrition 0.000 description 4
- 239000011975 tartaric acid Substances 0.000 description 4
- 235000002906 tartaric acid Nutrition 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 3
- 244000061520 Angelica archangelica Species 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- 240000003538 Chamaemelum nobile Species 0.000 description 3
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 3
- 235000007516 Chrysanthemum Nutrition 0.000 description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 3
- 241000723346 Cinnamomum camphora Species 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 3
- 240000006927 Foeniculum vulgare Species 0.000 description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 244000165082 Lavanda vera Species 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 3
- 240000009023 Myrrhis odorata Species 0.000 description 3
- 235000007265 Myrrhis odorata Nutrition 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 244000178231 Rosmarinus officinalis Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 229960000846 camphor Drugs 0.000 description 3
- 229930008380 camphor Natural products 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 229940105329 carboxymethylcellulose Drugs 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 description 3
- 229960001193 diclofenac sodium Drugs 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 229960001545 hydrotalcite Drugs 0.000 description 3
- 229910001701 hydrotalcite Inorganic materials 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000001102 lavandula vera Substances 0.000 description 3
- 229960002373 loxoprofen Drugs 0.000 description 3
- YMBXTVYHTMGZDW-UHFFFAOYSA-N loxoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1CC1C(=O)CCC1 YMBXTVYHTMGZDW-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- JSNRRGGBADWTMC-UHFFFAOYSA-N (6E)-7,11-dimethyl-3-methylene-1,6,10-dodecatriene Chemical compound CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 description 2
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- QQRSPHJOOXUALR-UHFFFAOYSA-N Apiole Chemical compound COC1=CC(CC=C)=C(OC)C2=C1OCO2 QQRSPHJOOXUALR-UHFFFAOYSA-N 0.000 description 2
- 241000208983 Arnica Species 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 description 2
- 244000056139 Brassica cretica Species 0.000 description 2
- 235000003351 Brassica cretica Nutrition 0.000 description 2
- 235000003343 Brassica rupestris Nutrition 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000005881 Calendula officinalis Nutrition 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 235000007862 Capsicum baccatum Nutrition 0.000 description 2
- 235000005940 Centaurea cyanus Nutrition 0.000 description 2
- 240000004385 Centaurea cyanus Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 description 2
- 244000301850 Cupressus sempervirens Species 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 206010016334 Feeling hot Diseases 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 235000017858 Laurus nobilis Nutrition 0.000 description 2
- 244000147568 Laurus nobilis Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 235000019501 Lemon oil Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- 235000019502 Orange oil Nutrition 0.000 description 2
- 244000062780 Petroselinum sativum Species 0.000 description 2
- 235000012550 Pimpinella anisum Nutrition 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 240000000785 Tagetes erecta Species 0.000 description 2
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 2
- 240000008866 Ziziphus nummularia Species 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 2
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000001728 capsicum frutescens Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- QRYRORQUOLYVBU-VBKZILBWSA-N carnosic acid Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 2
- NCEXYHBECQHGNR-UHFFFAOYSA-N chembl421 Chemical compound C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 2
- 239000010630 cinnamon oil Substances 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229960001681 croscarmellose sodium Drugs 0.000 description 2
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 2
- 229940015826 dihydroxyaluminum aminoacetate Drugs 0.000 description 2
- 229960000192 felbinac Drugs 0.000 description 2
- 239000012847 fine chemical Substances 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 239000010501 lemon oil Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 2
- 239000000347 magnesium hydroxide Substances 0.000 description 2
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 2
- 235000012254 magnesium hydroxide Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 235000010460 mustard Nutrition 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000011197 perejil Nutrition 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 239000010668 rosemary oil Substances 0.000 description 2
- 229940058206 rosemary oil Drugs 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 229920000247 superabsorbent polymer Polymers 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- MDKGKXOCJGEUJW-VIFPVBQESA-N (2s)-2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-VIFPVBQESA-N 0.000 description 1
- CXENHBSYCFFKJS-UHFFFAOYSA-N (3E,6E)-3,7,11-Trimethyl-1,3,6,10-dodecatetraene Natural products CC(C)=CCCC(C)=CCC=C(C)C=C CXENHBSYCFFKJS-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KBKGPMDADJLBEM-UHFFFAOYSA-N 1-(4-pentylphenyl)ethanone Chemical compound CCCCCC1=CC=C(C(C)=O)C=C1 KBKGPMDADJLBEM-UHFFFAOYSA-N 0.000 description 1
- XLTMWFMRJZDFFD-UHFFFAOYSA-N 1-[(2-chloro-4-nitrophenyl)diazenyl]naphthalen-2-ol Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C([N+]([O-])=O)C=C1Cl XLTMWFMRJZDFFD-UHFFFAOYSA-N 0.000 description 1
- IBIFTGXCJRFAMC-UHFFFAOYSA-N 2-(2-butoxyethyl)pyridine-3-carboxylic acid Chemical compound CCCCOCCC1=NC=CC=C1C(O)=O IBIFTGXCJRFAMC-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- XILVEPYQJIOVNB-UHFFFAOYSA-N 2-[3-(trifluoromethyl)anilino]benzoic acid 2-(2-hydroxyethoxy)ethyl ester Chemical compound OCCOCCOC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 XILVEPYQJIOVNB-UHFFFAOYSA-N 0.000 description 1
- CCJAYIGMMRQRAO-UHFFFAOYSA-N 2-[4-[(2-hydroxyphenyl)methylideneamino]butyliminomethyl]phenol Chemical compound OC1=CC=CC=C1C=NCCCCN=CC1=CC=CC=C1O CCJAYIGMMRQRAO-UHFFFAOYSA-N 0.000 description 1
- GNCOVOVCHIHPHP-UHFFFAOYSA-N 2-[[4-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-3-chlorophenyl]-2-chlorophenyl]diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC(C(=C1)Cl)=CC=C1C(C=C1Cl)=CC=C1N=NC(C(C)=O)C(=O)NC1=CC=CC=C1 GNCOVOVCHIHPHP-UHFFFAOYSA-N 0.000 description 1
- MWCBGWLCXSUTHK-UHFFFAOYSA-N 2-methylbutane-1,4-diol Chemical compound OCC(C)CCO MWCBGWLCXSUTHK-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- PSJBSUHYCGQTHZ-UHFFFAOYSA-N 3-Methoxy-1,2-propanediol Chemical compound COCC(O)CO PSJBSUHYCGQTHZ-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- VLDFMKOUUQYFGF-UHFFFAOYSA-N 4-(butoxymethyl)-2-methoxyphenol Chemical compound CCCCOCC1=CC=C(O)C(OC)=C1 VLDFMKOUUQYFGF-UHFFFAOYSA-N 0.000 description 1
- RFRMMZAKBNXNHE-UHFFFAOYSA-N 6-[4,6-dihydroxy-5-(2-hydroxyethoxy)-2-(hydroxymethyl)oxan-3-yl]oxy-2-(hydroxymethyl)-5-(2-hydroxypropoxy)oxane-3,4-diol Chemical compound CC(O)COC1C(O)C(O)C(CO)OC1OC1C(O)C(OCCO)C(O)OC1CO RFRMMZAKBNXNHE-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 240000006054 Agastache cana Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- WZUKKIPWIPZMAS-UHFFFAOYSA-K Ammonium alum Chemical compound [NH4+].O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O WZUKKIPWIPZMAS-UHFFFAOYSA-K 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000007258 Anthriscus cerefolium Nutrition 0.000 description 1
- 240000002022 Anthriscus cerefolium Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical compound CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 description 1
- 241001233914 Chelidonium majus Species 0.000 description 1
- 235000007519 Chimonanthus praecox Nutrition 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 235000002206 Daucus carota subsp carota Nutrition 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 244000039154 Erica Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 241000006118 Eucalyptus pulchella Species 0.000 description 1
- 235000014066 European mistletoe Nutrition 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- POPFMWWJOGLOIF-XWCQMRHXSA-N Flurandrenolide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O POPFMWWJOGLOIF-XWCQMRHXSA-N 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 241000501743 Gentiana macrophylla Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 235000008227 Illicium verum Nutrition 0.000 description 1
- 240000007232 Illicium verum Species 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 235000001835 Madeira lavender Nutrition 0.000 description 1
- SBDNJUWAMKYJOX-UHFFFAOYSA-N Meclofenamic Acid Chemical compound CC1=CC=C(Cl)C(NC=2C(=CC=CC=2)C(O)=O)=C1Cl SBDNJUWAMKYJOX-UHFFFAOYSA-N 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 235000015987 Origanum dictamnus Nutrition 0.000 description 1
- 240000001359 Origanum dictamnus Species 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 235000004383 Origanum vulgare subsp. vulgare Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000011751 Pogostemon cablin Nutrition 0.000 description 1
- 240000002505 Pogostemon cablin Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- TVQZAMVBTVNYLA-UHFFFAOYSA-N Pranoprofen Chemical compound C1=CC=C2CC3=CC(C(C(O)=O)C)=CC=C3OC2=N1 TVQZAMVBTVNYLA-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 244000152640 Rhipsalis cassutha Species 0.000 description 1
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 241000246358 Thymus Species 0.000 description 1
- 235000017715 Thymus pulegioides Nutrition 0.000 description 1
- 235000004054 Thymus serpyllum Nutrition 0.000 description 1
- 240000006001 Thymus serpyllum Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- WONIGEXYPVIKFS-UHFFFAOYSA-N Verbenol Chemical compound CC1=CC(O)C2C(C)(C)C1C2 WONIGEXYPVIKFS-UHFFFAOYSA-N 0.000 description 1
- 229920002978 Vinylon Polymers 0.000 description 1
- 244000172533 Viola sororia Species 0.000 description 1
- MUXFZBHBYYYLTH-UHFFFAOYSA-N Zaltoprofen Chemical compound O=C1CC2=CC(C(C(O)=O)C)=CC=C2SC2=CC=CC=C21 MUXFZBHBYYYLTH-UHFFFAOYSA-N 0.000 description 1
- 244000131415 Zanthoxylum piperitum Species 0.000 description 1
- FPVRUILUEYSIMD-RPRRAYFGSA-N [(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(C)=O)[C@@]1(C)C[C@@H]2O FPVRUILUEYSIMD-RPRRAYFGSA-N 0.000 description 1
- CELKVAQKCIJCLK-UHFFFAOYSA-N [9-(2-carboxyphenyl)-6-(diethylamino)xanthen-3-ylidene]-diethylazanium;octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC([O-])=O.C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O CELKVAQKCIJCLK-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- DGOBMKYRQHEFGQ-UHFFFAOYSA-L acid green 5 Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 DGOBMKYRQHEFGQ-UHFFFAOYSA-L 0.000 description 1
- YJVBLROMQZEFPA-UHFFFAOYSA-L acid red 26 Chemical compound [Na+].[Na+].CC1=CC(C)=CC=C1N=NC1=C(O)C(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=CC=C12 YJVBLROMQZEFPA-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 229960005142 alclofenac Drugs 0.000 description 1
- ARHWPKZXBHOEEE-UHFFFAOYSA-N alclofenac Chemical compound OC(=O)CC1=CC=C(OCC=C)C(Cl)=C1 ARHWPKZXBHOEEE-UHFFFAOYSA-N 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000011124 aluminium ammonium sulphate Nutrition 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- UGITYYUSJZBSQK-UHFFFAOYSA-K aluminum 2-aminoacetate hydroxide Chemical compound O[Al++].NCC([O-])=O.NCC([O-])=O UGITYYUSJZBSQK-UHFFFAOYSA-K 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- LCPUDZUWZDSKMX-UHFFFAOYSA-K azane;hydrogen sulfate;iron(3+);sulfate;dodecahydrate Chemical compound [NH4+].O.O.O.O.O.O.O.O.O.O.O.O.[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O LCPUDZUWZDSKMX-UHFFFAOYSA-K 0.000 description 1
- LFZDEAVRTJKYAF-UHFFFAOYSA-L barium(2+) 2-[(2-hydroxynaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate Chemical compound [Ba+2].C1=CC=CC2=C(S([O-])(=O)=O)C(N=NC3=C4C=CC=CC4=CC=C3O)=CC=C21.C1=CC=CC2=C(S([O-])(=O)=O)C(N=NC3=C4C=CC=CC4=CC=C3O)=CC=C21 LFZDEAVRTJKYAF-UHFFFAOYSA-L 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229940092705 beclomethasone Drugs 0.000 description 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
- 229960005149 bendazac Drugs 0.000 description 1
- BYFMCKSPFYVMOU-UHFFFAOYSA-N bendazac Chemical compound C12=CC=CC=C2C(OCC(=O)O)=NN1CC1=CC=CC=C1 BYFMCKSPFYVMOU-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- AKUJBENLRBOFTD-QZIXMDIESA-N betamethasone acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(C)=O)(O)[C@@]1(C)C[C@@H]2O AKUJBENLRBOFTD-QZIXMDIESA-N 0.000 description 1
- 229960004648 betamethasone acetate Drugs 0.000 description 1
- 229960001102 betamethasone dipropionate Drugs 0.000 description 1
- CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 description 1
- SNHRLVCMMWUAJD-SUYDQAKGSA-N betamethasone valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 description 1
- 229960004311 betamethasone valerate Drugs 0.000 description 1
- 235000005770 birds nest Nutrition 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CYHOWEBNQPOWEI-UHFFFAOYSA-L calcium 3-carboxy-1-phenyldiazenylnaphthalen-2-olate Chemical compound OC=1C(=CC2=CC=CC=C2C1N=NC1=CC=CC=C1)C(=O)[O-].OC=1C(=CC2=CC=CC=C2C1N=NC1=CC=CC=C1)C(=O)[O-].[Ca+2] CYHOWEBNQPOWEI-UHFFFAOYSA-L 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 235000012255 calcium oxide Nutrition 0.000 description 1
- 239000010624 camphor oil Substances 0.000 description 1
- 229960000411 camphor oil Drugs 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229930185631 capsicoside Natural products 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- PMRJYBALQVLLSJ-UHFFFAOYSA-N chamazulene Natural products CCC1=CC2=C(C)CCC2=CC=C1 PMRJYBALQVLLSJ-UHFFFAOYSA-N 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- ONTQJDKFANPPKK-UHFFFAOYSA-L chembl3185981 Chemical compound [Na+].[Na+].CC1=CC(C)=C(S([O-])(=O)=O)C=C1N=NC1=CC(S([O-])(=O)=O)=C(C=CC=C2)C2=C1O ONTQJDKFANPPKK-UHFFFAOYSA-L 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000010632 citronella oil Substances 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 229960004703 clobetasol propionate Drugs 0.000 description 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003657 dexamethasone acetate Drugs 0.000 description 1
- PGZIKUPSQINGKT-UHFFFAOYSA-N dialuminum;dioxido(oxo)silane Chemical compound [Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O PGZIKUPSQINGKT-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229960000616 diflunisal Drugs 0.000 description 1
- HUPFGZXOMWLGNK-UHFFFAOYSA-N diflunisal Chemical compound C1=C(O)C(C(=O)O)=CC(C=2C(=CC(F)=CC=2)F)=C1 HUPFGZXOMWLGNK-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- MQWPIYMKAKYEEQ-UHFFFAOYSA-L dipotassium 2,3,4,5-tetrachloro-6-(2,4,5,7-tetrabromo-3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [K+].[K+].[O-]C(=O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(Br)c([O-])c(Br)c2oc2c(Br)c(=O)c(Br)cc12 MQWPIYMKAKYEEQ-UHFFFAOYSA-L 0.000 description 1
- GZAAPEKTGHKWRZ-UHFFFAOYSA-L dipotassium;2-(2,4,5,7-tetrabromo-3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [K+].[K+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GZAAPEKTGHKWRZ-UHFFFAOYSA-L 0.000 description 1
- VQHHOXOLUXRQFQ-UHFFFAOYSA-L dipotassium;4,5,6,7-tetrachloro-2',4',5',7'-tetraiodo-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [K+].[K+].O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C([O-])C(I)=C1OC1=C(I)C([O-])=C(I)C=C21 VQHHOXOLUXRQFQ-UHFFFAOYSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940120889 dipyrone Drugs 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- IVKWXPBUMQZFCW-UHFFFAOYSA-L disodium;2-(2,4,5,7-tetraiodo-3-oxido-6-oxoxanthen-9-yl)benzoate;hydrate Chemical compound O.[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IVKWXPBUMQZFCW-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 229960005293 etodolac Drugs 0.000 description 1
- XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
- 229960001493 etofenamate Drugs 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 229930009668 farnesene Natural products 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960001395 fenbufen Drugs 0.000 description 1
- ZPAKPRAICRBAOD-UHFFFAOYSA-N fenbufen Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1C1=CC=CC=C1 ZPAKPRAICRBAOD-UHFFFAOYSA-N 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229960004511 fludroxycortide Drugs 0.000 description 1
- 229960004369 flufenamic acid Drugs 0.000 description 1
- LPEPZBJOKDYZAD-UHFFFAOYSA-N flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 description 1
- 229960003469 flumetasone Drugs 0.000 description 1
- WXURHACBFYSXBI-GQKYHHCASA-N flumethasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O WXURHACBFYSXBI-GQKYHHCASA-N 0.000 description 1
- 229960001347 fluocinolone acetonide Drugs 0.000 description 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
- 229960001048 fluorometholone Drugs 0.000 description 1
- FAOZLTXFLGPHNG-KNAQIMQKSA-N fluorometholone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@]2(F)[C@@H](O)C[C@]2(C)[C@@](O)(C(C)=O)CC[C@H]21 FAOZLTXFLGPHNG-KNAQIMQKSA-N 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 229920003112 high viscosity grade hydroxypropyl cellulose Polymers 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 235000001793 lemon lavender Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229960003803 meclofenamic acid Drugs 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 229960001293 methylprednisolone acetate Drugs 0.000 description 1
- PLBHSZGDDKCEHR-LFYFAGGJSA-N methylprednisolone acetate Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(C)=O)CC[C@H]21 PLBHSZGDDKCEHR-LFYFAGGJSA-N 0.000 description 1
- 229930003647 monocyclic monoterpene Natural products 0.000 description 1
- 150000002767 monocyclic monoterpene derivatives Chemical class 0.000 description 1
- JMXROTHPANUTOJ-UHFFFAOYSA-H naphthol green b Chemical compound [Na+].[Na+].[Na+].[Fe+3].C1=C(S([O-])(=O)=O)C=CC2=C(N=O)C([O-])=CC=C21.C1=C(S([O-])(=O)=O)C=CC2=C(N=O)C([O-])=CC=C21.C1=C(S([O-])(=O)=O)C=CC2=C(N=O)C([O-])=CC=C21 JMXROTHPANUTOJ-UHFFFAOYSA-H 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- ZYIBVBKZZZDFOY-UHFFFAOYSA-N phloxine O Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 ZYIBVBKZZZDFOY-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940050271 potassium alum Drugs 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 229960003101 pranoprofen Drugs 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- BOFKYYWJAOZDPB-FZNHGJLXSA-N prednival Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O BOFKYYWJAOZDPB-FZNHGJLXSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- KXXXUIKPSVVSAW-UHFFFAOYSA-K pyranine Chemical compound [Na+].[Na+].[Na+].C1=C2C(O)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 KXXXUIKPSVVSAW-UHFFFAOYSA-K 0.000 description 1
- TVRGPOFMYCMNRB-UHFFFAOYSA-N quinizarine green ss Chemical compound C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1 TVRGPOFMYCMNRB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940077082 red pepper extract Drugs 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229960000581 salicylamide Drugs 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- VVNRQZDDMYBBJY-UHFFFAOYSA-M sodium 1-[(1-sulfonaphthalen-2-yl)diazenyl]naphthalen-2-olate Chemical compound [Na+].C1=CC=CC2=C(S([O-])(=O)=O)C(N=NC3=C4C=CC=CC4=CC=C3O)=CC=C21 VVNRQZDDMYBBJY-UHFFFAOYSA-M 0.000 description 1
- LGZQSRCLLIPAEE-UHFFFAOYSA-M sodium 1-[(4-sulfonaphthalen-1-yl)diazenyl]naphthalen-2-olate Chemical compound [Na+].C1=CC=C2C(N=NC3=C4C=CC=CC4=CC=C3O)=CC=C(S([O-])(=O)=O)C2=C1 LGZQSRCLLIPAEE-UHFFFAOYSA-M 0.000 description 1
- CGXSFOUXEQBDCJ-UHFFFAOYSA-N sodium;8-hydroxy-5,7-dinitronaphthalene-2-sulfonic acid Chemical compound [Na+].C1=C(S(O)(=O)=O)C=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 CGXSFOUXEQBDCJ-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
- 229960000894 sulindac Drugs 0.000 description 1
- 229960004492 suprofen Drugs 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229940036248 turpentine Drugs 0.000 description 1
- 244000199671 umbrella grass Species 0.000 description 1
- 235000005468 umbrella grass Nutrition 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 229940078465 vanillyl butyl ether Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000005765 wild carrot Nutrition 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 229950004227 zaltoprofen Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J11/00—Features of adhesives not provided for in group C09J9/00, e.g. additives
- C09J11/02—Non-macromolecular additives
- C09J11/06—Non-macromolecular additives organic
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J133/00—Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
- C09J133/02—Homopolymers or copolymers of acids; Metal or ammonium salts thereof
Abstract
점착제층과 지지체를 구비한 첩부제로서,
상기 점착제층이,
(A) 폴리아크릴산 및 그 염으로부터 선택되는 1종 이상,
(B) 25℃에서의 1질량% 수용액 점도가 2,000mPa·s 이하인 카르복시메틸셀룰로오스나트륨 및 25℃에서의 1질량% 수용액 점도가 2,500mPa·s 이상인 카르복시메틸셀룰로오스나트륨을 포함하는 셀룰로오스 유도체,
(C) 다가 알코올, 및
(D) 다가 금속염을 함유하는 첩부제.As a patch provided with an adhesive layer and a support,
The pressure-sensitive adhesive layer,
(A) one or more selected from polyacrylic acid and salts thereof,
(B) a cellulose derivative comprising sodium carboxymethylcellulose having a viscosity of 1 mass% aqueous solution at 25°C of 2,000 mPa·s or less and sodium carboxymethyl cellulose having a viscosity of 1 mass% aqueous solution at 25°C of 2,500 mPa·s or more,
(C) polyhydric alcohol, and
(D) A patch containing a polyvalent metal salt.
Description
본 발명은 고함수 점착제층을 구비한 첩부제 및 그 제조 방법에 관한 것이다.The present invention relates to a patch provided with a high water content pressure-sensitive adhesive layer and a method for producing the same.
고함수량의 점착제층을 구비한 첩부제는 냉각 효과의 지속성이 우수하다. 고함수량의 점착제층에는 카르복시메틸셀룰로오스나트륨(이하, CMCNa로 기재하는 경우가 있음)이 사용되는 경우가 있다. 일반적인 점착제층의 제조 공정에서는 CMCNa를 분산제인 다가 알코올에 분산시킴으로써 점착층 중에 균일하게 분산시켜 용해시키고 있다(특허문헌 1: 일본특허공개 2014-028767호 공보). 그러나, 다가 알코올에의 분산 시, 분산액 중의 CMCNa 농도가 높은 상태이면, 점착층 중에 균일하게 분산시킬 수 없어 불용해 응집물이 생긴다는 과제가 있었다. 또한, 불용해 응집물을 해소하기 위해서 장시간의 교반을 하면, 점착제층의 온도가 상승함으로써 경화가 빨라져 전연할 수 없는 등의 제조상의 문제가 발생하고 있었다.The patch having a high water content pressure-sensitive adhesive layer is excellent in persistence of the cooling effect. In some cases, sodium carboxymethylcellulose (hereinafter, sometimes referred to as CMCNa) is used for the pressure-sensitive adhesive layer having a high water content. In a general pressure-sensitive adhesive layer manufacturing process, CMCNa is uniformly dispersed and dissolved in the pressure-sensitive adhesive layer by dispersing CMCNa in polyhydric alcohol as a dispersant (Patent Document 1: Japanese Patent Laid-Open No. 2014-028767). However, upon dispersion in a polyhydric alcohol, if the CMCNa concentration in the dispersion is high, there is a problem that it cannot be uniformly dispersed in the adhesive layer, and insoluble aggregates are generated. In addition, when stirring for a long time in order to eliminate the insoluble aggregates, the temperature of the pressure-sensitive adhesive layer rises, resulting in a problem in production such as rapid curing and inability to spread.
이것에 대하여 함수율 70질량% 미만에서는 다가 알코올을 다량으로 사용함으로써 CMCNa의 분산 효율을 좋게 할 수 있다. 그러나, 함수율이 70질량% 이상인 고함수량의 점착제층의 경우에는 다가 알코올의 배합량에 상한이 있기 때문에 CMCNa가 다가 알코올 중에서 고농도가 되어 불용해 응집물이 생긴다는 상기 과제를 해소할 수 없었다(특허문헌 2: 일본특허공개 2002-136587호 공보).On the other hand, when the moisture content is less than 70% by mass, the dispersion efficiency of CMCNa can be improved by using a large amount of polyhydric alcohol. However, in the case of a high moisture pressure-sensitive adhesive layer having a water content of 70% by mass or more, since there is an upper limit on the blending amount of polyhydric alcohol, the above problem that CMCNa becomes a high concentration in the polyhydric alcohol, resulting in insoluble aggregates could not be solved (Patent Document 2 : Japanese Patent Publication No. 2002-136587).
한편, 다가 알코올과 고흡수성 고분자 화합물을 병용하여 점착제층 중에 균일하게 분산시키는 방법이 알려져 있지만(특허문헌 3: 일본특허공개 2001-122772호 공보), 고흡수성 고분자는 고가인데다가, 가소제인 다가 알코올이 적기 때문에 건조 시 고체(膏體)가 단단해져 첩부제를 벗길 때 등에 통증을 느끼는 경우가 있다는 과제가 있었다.On the other hand, a method of uniformly dispersing a polyhydric alcohol and a superabsorbent polymer compound in the pressure-sensitive adhesive layer is known (Patent Document 3: Japanese Patent Laid-Open No. 2001-122772), but the superabsorbent polymer is expensive, and polyhydric alcohol, which is a plasticizer. Because of this small amount, there has been a problem in that the solid becomes hard during drying, and pain may be felt in the back when peeling off the patch.
본 발명은 상기 사정을 감안하여 이루어진 것이며, 점착제층 중의 불용해 응집물의 발생을 억제함과 아울러 첩부제의 벗겨짐·말림 및 이면 얼룩(점착제층의 지지체 이면에의 스며나옴)이 억제된 첩부제를 제공하는 것을 목적으로 한다.The present invention has been made in view of the above circumstances, and suppresses the occurrence of insoluble aggregates in the pressure-sensitive adhesive layer, and suppresses peeling, curling, and unevenness on the back surface of the patch (seepage to the back surface of the support of the adhesive layer). It aims to provide.
본 발명자들은 상기 목적을 달성하기 위해 예의 검토한 결과, 함수율이 70질량% 이상인 점착제층과 지지체를 구비한 첩부제로서, 특정량의 (A) 폴리아크릴산 및 그 염으로부터 선택되는 1종 이상, 특정량의 (B) 카르복시메틸셀룰로오스나트륨을 필수로 하는 셀룰로오스 유도체, (C) 다가 알코올, 및 (D) 다가 금속염을 함유하는 첩부제로 함으로써 상기 과제를 해결할 수 있는 것을 지견하여 본 발명을 이루기에 도달한 것이다.The inventors of the present invention have studied intensively in order to achieve the above object, as a result of an adhesive layer having a water content of 70% by mass or more, and a patch having a support, a specific amount of at least one selected from (A) polyacrylic acid and its salt, specific Amount of (B) carboxymethylcellulose sodium as essential cellulose derivative, (C) polyhydric alcohol, and (D) a patch containing a polyvalent metal salt found that the above problems could be solved, and thus achieved the present invention. will be.
따라서, 본 발명은 첩부제 및 그 제조 방법을 제공한다.Accordingly, the present invention provides a patch and a method for producing the patch.
1. 함수율이 70질량% 이상인 점착제층과 지지체를 구비한 첩부제로서, 1. As a patch provided with an adhesive layer and a support having a water content of 70% by mass or more,
상기 점착제층이,The pressure-sensitive adhesive layer,
(A) 폴리아크릴산 및 그 염으로부터 선택되는 1종 이상,(A) one or more selected from polyacrylic acid and salts thereof,
(B) 25℃에서의 1질량% 수용액 점도가 2,000mPa·s 이하인 카르복시메틸셀룰로오스나트륨 및 25℃에서의 1질량% 수용액 점도가 2,500mPa·s 이상인 카르복시메틸셀룰로오스나트륨을 포함하는 셀룰로오스 유도체,(B) a cellulose derivative comprising sodium carboxymethylcellulose having a viscosity of 1 mass% aqueous solution at 25°C of 2,000 mPa·s or less and sodium carboxymethyl cellulose having a viscosity of 1 mass% aqueous solution at 25°C of 2,500 mPa·s or more,
(C) 다가 알코올, 및(C) polyhydric alcohol, and
(D) 다가 금속염을 함유하는 첩부제.(D) A patch containing a polyvalent metal salt.
2. 1에 있어서, 2. In 1,
(A) 성분의 함유량이 점착제층 중 2.4~10.0질량%,The content of the component (A) is 2.4 to 10.0% by mass in the pressure-sensitive adhesive layer,
(B) 성분의 함유량이 점착제층 중 1.5~5.4질량%이며,The content of the component (B) is 1.5 to 5.4 mass% in the pressure-sensitive adhesive layer,
식(I): [(A)성분의 함유량]/[(B)성분의 함유량](질량비)가 1.0~6.67이고, 또한, Formula (I): [content of (A) component]/[content of (B) component] (mass ratio) is 1.0 to 6.67, and,
식(II): [(C)성분의 함유량]/{1.5×[(A)성분의 함유량]+2×[(B)성분의 함유량]}(질량비)가 1~3인 첩부제.Formula (II): [content of (C) component]/{1.5 x [content of (A) component] + 2 x [content of (B) component]} (mass ratio) of 1 to 3 patch.
3. 1 또는 2에 있어서, 3. In 1 or 2,
(C)성분의 함유량이 점착제층 중 11~25.2질량%인 첩부제.(C) A patch in which the content of the component is 11 to 25.2% by mass in the pressure-sensitive adhesive layer.
4. 1 내지 3 중 어느 하나에 있어서, 4. In any one of 1 to 3,
(D)성분의 함유량이 점착제층 중 0.01~2질량%인 첩부제.(D) A patch in which the content of the component is 0.01 to 2% by mass in the pressure-sensitive adhesive layer.
5. 1 내지 4 중 어느 하나에 있어서, 5. In any one of 1 to 4,
(E) 유효 성분, 청량화제 및 온감 부여제로부터 선택되는 1종 이상을 더 함유하는 첩부제. (E) A patch further containing at least one selected from an active ingredient, a refreshing agent, and a warmth imparting agent.
6. 1 내지 5 중 어느 하나에 기재된 첩부제의 제조 방법으로서,6. As a method for producing a patch according to any one of 1 to 5,
(A) 폴리아크릴산 및 그 염으로부터 선택되는 1종 이상과, (B) 셀룰로오스 유도체를 (C) 다가 알코올에 분산시키는 공정을 포함하는 첩부제의 제조 방법.(A) At least one selected from polyacrylic acid and salts thereof, and (B) a method for producing a patch comprising a step of dispersing a cellulose derivative in (C) a polyhydric alcohol.
7. 6에 있어서, 7. In 6,
(A)성분 및 (B)성분이 분체인 첩부제의 제조 방법.(A) component and (B) component are the manufacturing method of the patch which is powder.
(발명의 효과)(Effects of the Invention)
본 발명에 의하면, 점착제층 중의 불용해 응집물의 발생을 억제함과 아울러 첩부제의 벗겨짐·말림 및 이면 얼룩이 억제된 첩부제 및 그 제조 방법을 제공할 수 있다.ADVANTAGE OF THE INVENTION According to this invention, while suppressing the generation|occurrence|production of an insoluble aggregate in an adhesive layer, peeling, curling, and the back surface unevenness of a patch were suppressed, a patch and its manufacturing method can be provided.
이하, (i) 점착제층, (ii) 점착제층의 제조 방법, (iii) 지지체, (iv) 첩부제 및 그 제조 방법으로 나누어 상세히 설명한다.Hereinafter, (i) a pressure-sensitive adhesive layer, (ii) a method of manufacturing the pressure-sensitive adhesive layer, (iii) a support, (iv) a patch, and a manufacturing method thereof will be described in detail.
(i) 점착제층(i) adhesive layer
[(A)성분][(A) component]
(A)성분은 폴리아크릴산 및 그 염으로부터 선택되는 1종 이상이며, 주로 점착제로서 작용한다. (A)성분으로서는 폴리아크릴산, 폴리아크릴산의 전부가 중화(폴리아크릴산염), 또는 일부가 중화(폴리아크릴산 부분 중화물)된 중화물, 가교형 폴리아크릴산 및 그 염을 들 수 있다. 폴리아크릴산염 또는 폴리아크릴산 부분 중화물의 반대 이온으로서 나트륨, 칼륨 등의 1가 금속염, 모노에탄올아민, 디에탄올아민, 트리에탄올아민 등의 아민염, 암모늄염으로 중화한 것을 들 수 있다. 이들은 1종류 단독으로 또는 2종류 이상을 적당히 조합해서 사용할 수 있다. 또한, (A)성분은 분체가 바람직하다.The component (A) is one or more selected from polyacrylic acid and salts thereof, and mainly acts as an adhesive. Examples of the component (A) include polyacrylic acid, a neutralized product in which all of the polyacrylic acid is neutralized (polyacrylic acid salt) or partially neutralized (partially neutralized polyacrylic acid), a crosslinked polyacrylic acid, and a salt thereof. Examples of the counter ion of the polyacrylic acid salt or the partially neutralized polyacrylic acid include monovalent metal salts such as sodium and potassium, amine salts such as monoethanolamine, diethanolamine, and triethanolamine, and those neutralized with an ammonium salt. These can be used alone or in combination of two or more as appropriate. In addition, powder is preferable as for (A) component.
(A)성분의 질량 평균 분자량으로서는 특별히 제한은 없지만, 400만~500만이 바람직하다. 또한 폴리아크릴산 부분 중화물의 중화도는 10~50mol%가 바람직하고, 20~40mol%가 보다 바람직하고, 40mol%가 더욱 바람직하다. 또한, 0.2질량% 수용액 점도(B형 점도계: 로터 No.2, 회전수 30rpm, 20℃)는 100~10,000mPa·s가 바람직하고, 100~5,000mPa·s가 보다 바람직하고, 100~1,000mPa·s가 더욱 바람직하다. 또한, 질량 평균 분자량의 측정 방법은 겔 투과 크로마토그래피(GPC), 중화도는 하기 식으로 구해지는 값이다. Although there is no restriction|limiting in particular as a mass average molecular weight of (A) component, 4 million-5 million are preferable. Further, the degree of neutralization of the partially neutralized polyacrylic acid is preferably 10 to 50 mol%, more preferably 20 to 40 mol%, and even more preferably 40 mol%. In addition, the 0.2 mass% aqueous solution viscosity (B type viscometer: rotor No. 2, rotational speed 30 rpm, 20°C) is preferably 100 to 10,000 mPa·s, more preferably 100 to 5,000 mPa·s, and 100 to 1,000 mPa -S is more preferable. In addition, the measurement method of the mass average molecular weight is gel permeation chromatography (GPC), and the neutralization degree is a value calculated|required by the following formula.
중화도(mol%)=100×「분자 중의 중화되어 있는 카르복실기의 몰수」/「분자가 갖는 카르복실기의 총 몰수」Degree of neutralization (mol%) = 100 × "the number of moles of neutralized carboxyl groups in the molecule" / "the total number of moles of carboxyl groups in the molecule"
(A)성분의 함유량은 점착제층 중 2.4~10.0질량%가 바람직하고, 3~9질량%가 보다 바람직하고, 5~8.4질량%가 더욱 바람직하다. 2.4질량% 이상으로 함으로써 점착력이 보다 향상되어 첩부제의 벗겨짐·말림을 보다 억제할 수 있고, 불용해 응집물이 보다 생기기 어려워진다. 한편, 10.0질량% 이하로 함으로써 후술하는 식(I), (II)] 및 함수율 70질량% 이상을 충족할 수 있다.The content of the component (A) is preferably 2.4 to 10.0% by mass, more preferably 3 to 9% by mass, and still more preferably 5 to 8.4% by mass in the pressure-sensitive adhesive layer. By setting it as 2.4 mass% or more, adhesive force is improved more, peeling and curling of a patch can be suppressed more, and insoluble aggregates become more difficult to produce. On the other hand, by setting it as 10.0 mass% or less, formula (I) and (II) mentioned later and a water content of 70 mass% or more can be satisfied.
[(B)성분][(B) component]
(B)성분은 25℃에서의 1질량% 수용액 점도가 2,000mPa·s 이하, 바람직하게는 1,000~2,000mPa·s인 카르복시메틸셀룰로오스나트륨 및 25℃에서의 1질량% 수용액 점도가 2,500mPa·s 이상, 바람직하게는 2,500~4,500mPa·s인 카르복시메틸셀룰로오스나트륨을 포함하는 셀룰로오스 유도체이며, 주로 보형 부여로서 작용한다. 25℃에서의 1질량% 수용액 점도가 2,000mPa·s 이하인 카르복시메틸셀룰로오스나트륨/25℃에서의 1질량% 수용액 점도가 2,500mPa·s 이상인 카르복시메틸셀룰로오스나트륨으로 나타내어지는 배합 질량비는 1/3~3/1이 바람직하다.Component (B) has a viscosity of 1% by mass aqueous solution at 25°C of 2,000 mPa·s or less, preferably 1,000 to 2,000 mPa·s of sodium carboxymethylcellulose, and a viscosity of 1% by mass aqueous solution at 25°C of 2,500 mPa·s. As described above, it is a cellulose derivative containing sodium carboxymethylcellulose, preferably 2,500 to 4,500 mPa·s, and mainly acts as an imparting shape. The blending mass ratio represented by sodium carboxymethylcellulose having a viscosity of 1 mass% aqueous solution at 25°C of 2,000 mPa·s or less/sodium carboxymethyl cellulose having a viscosity of 1 mass% aqueous solution at 25°C of 2,500 mPa·s or more is 1/3 to 3 /1 is preferred.
또한, (B)성분의 점도의 측정 방법은 BL 점도계를 사용한다. 25℃에서의 1질량% 수용액 점도 1,000mPa·s 미만은 로터 No.1~3을 사용하여 회전수 60rpm으로 측정하고, 25℃에서의 1질량% 수용액 점도 1,000~2,000mPa·s는 로터 No.3 또는 No.4를 사용하여 회전수 60rpm으로 측정하고, 25℃에서의 1질량% 수용액 점도 2,500~4,500mPa·s는 로터 No.4를 사용하여 회전수 60rpm으로 측정한다.In addition, the measuring method of the viscosity of (B) component uses a BL viscometer. A 1 mass% aqueous solution viscosity at 25°C of less than 1,000 mPa·s is measured at a rotation speed of 60 rpm using rotor Nos. 1-3, and a 1 mass% aqueous solution viscosity at 25° C. of 1,000 to 2,000 mPa·s is a rotor No. 3 or No. 4 is used to measure at a rotation speed of 60 rpm, and a viscosity of 2,500 to 4,500 mPa·s in a 1% by mass aqueous solution at 25°C is measured at a rotation speed of 60 rpm using a rotor No. 4.
(B)성분은 상기 점도가 상이한 2종의 카르복시메틸셀룰로오스나트륨을 필수성분으로 하지만, 그 외 (B) 성분의 셀룰로오스 유도체로서는 카르복시메틸셀룰로오스, 히드록시프로필셀룰로오스, 히드록시에틸셀룰로오스, 히드록시프로필메틸셀룰로오스, 히드록시프로필히드록시에틸셀룰로오스, 히드록시에틸메틸셀룰로오스, 히드록시메틸셀룰로오스, 메틸셀룰로오스, 크로스카르멜로오스나트륨 등의 수용성 셀룰로오스에테르, 양이온화 셀룰로오스, 이들의 염 등을 들 수 있다. 카르복시메틸셀룰로오스나트륨과 병용하는 셀룰로오스 유도체로서는 카르복시메틸셀룰로오스, 히드록시프로필셀룰로오스, 크로스카르멜로오스나트륨이 바람직하다. 제조성 및 겔의 보형성의 관점으로부터 (B)성분 중의 카르복시메틸셀룰로오스나트륨의 비율로서는 70~100질량%가 바람직하다. 카르복시메틸셀룰로오스나트륨의 점착제층 중의 양은 2~5질량%가 바람직하다. 또한, (B)성분은 분체가 바람직하다.Component (B) contains two kinds of sodium carboxymethylcellulose having different viscosities as essential components, but the cellulose derivatives of component (B) include carboxymethylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, and hydroxypropylmethyl. And water-soluble cellulose ethers such as cellulose, hydroxypropylhydroxyethylcellulose, hydroxyethylmethylcellulose, hydroxymethylcellulose, methylcellulose, and croscarmellose sodium, cationized cellulose, and salts thereof. As a cellulose derivative used in combination with sodium carboxymethylcellulose, carboxymethylcellulose, hydroxypropylcellulose, and croscarmellose sodium are preferable. From the viewpoint of manufacturability and gel retention, the ratio of sodium carboxymethylcellulose in the component (B) is preferably 70 to 100% by mass. The amount of sodium carboxymethylcellulose in the pressure-sensitive adhesive layer is preferably 2 to 5% by mass. In addition, as for the component (B), powder is preferable.
(B)성분의 함유량은 점착제층 중 1.5~5.4질량%가 바람직하고, 2~5질량%가 보다 바람직하고, 3~4질량%가 더욱 바람직하다. (B)성분을 1.5질량% 이상으로 함으로써 이면 얼룩이 보다 억제된다. 5.4질량% 이하로 함으로써 후술하는 식(I), (II) 및 함수율 70질량% 이상을 충족할 수 있다.The content of the component (B) is preferably 1.5 to 5.4 mass%, more preferably 2 to 5 mass%, and still more preferably 3 to 4 mass% in the pressure-sensitive adhesive layer. By making the component (B) 1.5% by mass or more, unevenness on the back surface is more suppressed. By setting it as 5.4 mass% or less, formulas (I) and (II) mentioned later and a water content of 70 mass% or more can be satisfied.
[(C)성분][(C) ingredient]
(C)성분은 다가 알코올이며, 상기 (A)성분, (B)성분의 분산제로서 주로 작용한다. 다가 알코올로서는 에틸렌글리콜, 1,3-부탄디올, 프로필렌글리콜, 이소프렌글리콜, 아밀렌글리콜, 글리세린, 디글리세린, 트리글리세린, 폴리글리세린, 디에틸렌글리콜, 디프로필렌글리콜, 폴리에틸렌글리콜, 디에틸렌글리콜모노알킬에테르 등을 들 수 있고, 1종 단독으로 또는 2종 이상을 적당히 조합해서 사용할 수 있다. 그 중에서도 글리세린을 사용하는 것이 바람직하다.The component (C) is a polyhydric alcohol, and mainly acts as a dispersant for the component (A) and component (B). Polyhydric alcohols include ethylene glycol, 1,3-butanediol, propylene glycol, isoprene glycol, amylene glycol, glycerin, diglycerin, triglycerin, polyglycerin, diethylene glycol, dipropylene glycol, polyethylene glycol, diethylene glycol monoalkyl ether And the like, and can be used alone or in combination of two or more as appropriate. Among them, it is preferable to use glycerin.
(C)성분의 함유량은 점착제층 중 11~25.2질량%가 바람직하고, 15~20질량%가 보다 바람직하고, 16~20질량%가 더욱 바람직하다. (C)성분의 함유량을 11질량% 이상으로 함으로써 사용 중에 있어서의 점착제층의 유연성을 유지할 수 있고, (A) 및 (B)성분이 점착제층 중에 균일 용해되어 불용해 응집물이 보다 생기기 어려워진다. 25.2질량% 이하로 함으로써 후술하는 식(I), (II) 및 함수율 70질량% 이상을 충족할 수 있다.The content of the component (C) is preferably 11 to 25.2% by mass, more preferably 15 to 20% by mass, and still more preferably 16 to 20% by mass in the pressure-sensitive adhesive layer. By setting the content of the component (C) to 11% by mass or more, the flexibility of the pressure-sensitive adhesive layer in use can be maintained, and the components (A) and (B) are uniformly dissolved in the pressure-sensitive adhesive layer, making it more difficult to form insoluble aggregates. By setting it as 25.2 mass% or less, formulas (I) and (II) mentioned later and a water content of 70 mass% or more can be satisfied.
식(I): [(A)성분의 함유량]/[(B)성분의 함유량](질량비)는 (B)성분에 대한 (A)성분의 함유량을 규정한 것이며, 1~6.67이 바람직하고, 1~4.5가 보다 바람직하고, 1.25~2.8이 더욱 바람직하다. 이 비를 1 이상으로 함으로써 (A) 및 (B)성분이 점착제층 중에 균일 용해되어 불용해 응집물이 보다 생기기 어려워진다. 또한, 1 이상으로 함으로써 첩부제의 벗겨짐·말림이 보다 억제되기 쉬워진다. 한편, 6.67이하로 함으로써 후술하는 식(II) 및 함수율 70질량% 이상을 충족할 수 있다.Formula (I): [content of the component (A)]/[content of the component (B)] (mass ratio) defines the content of the component (A) relative to the component (B), and is preferably 1 to 6.67, 1 to 4.5 are more preferable, and 1.25 to 2.8 are still more preferable. By setting this ratio to 1 or more, the components (A) and (B) are uniformly dissolved in the pressure-sensitive adhesive layer, and insoluble aggregates are more difficult to form. Further, by setting it as 1 or more, peeling and curling of the patch is more easily suppressed. On the other hand, by setting it as 6.67 or less, Formula (II) mentioned later and a moisture content 70 mass% or more can be satisfied.
식(II): [(C)성분의 함유량]/{1.5×[(A)성분의 함유량]+2×[(B)성분의 함유량]}(질량비)는 분산제로서 작용하는 다가 알코올의 필요량을 규정한 것이며, 1~3이 바람직하다. 상기 식은 (A)성분, 및 (B)성분을 (C)성분 중에 균일하게 분산시키고 또한 점착제층 중에 균일하게 용해가능한 양을 (A)성분, (B)성분 각각으로 규정한 것이며, (A)성분에 대하여 1.5배량의 (C)성분과, (B)성분에 대하여 2배량의 (C)성분이 필요한 것을 의미한다. 이 비를 1 이상으로 함으로써 (A) 및 (B)성분이 점착제층 중에 균일 용해되어 불용해 응집물이 보다 생기기 어려워진다. 한편, 3 이하로 함으로써 상술의 식(I) 및 함수율 70질량% 이상을 충족할 수 있다.Formula (II): [content of (C) component]/{1.5 x [content of (A) component] + 2 x [content of (B) component]} (mass ratio) indicates the required amount of polyhydric alcohol acting as a dispersant It is defined, and 1-3 are preferable. The above formula defines the amount of (A) component and (B) component uniformly dispersed in (C) component and uniformly soluble in the pressure-sensitive adhesive layer as each of (A) component and (B) component, and (A) It means that 1.5 times the amount of component (C) and 2 times the amount of component (C) with respect to the component are required. By setting this ratio to 1 or more, the components (A) and (B) are uniformly dissolved in the pressure-sensitive adhesive layer, and insoluble aggregates are more difficult to form. On the other hand, by setting it as 3 or less, above-mentioned Formula (I) and water content 70 mass% or more can be satisfied.
[(D)성분][(D) ingredient]
(D)성분은 다가 금속염이며, 가교제로서 작용한다. 다가 금속염으로서는 칼륨 명반, 암모늄 명반, 철 명반 등의 명반류, 수산화알루미늄, 황산알루미늄, 염화알루미늄, 아세트산알루미늄, 산화알류미늄, 규산알루미늄, 메타규산알루미늄, 수산화칼슘, 탄산칼슘, 인산칼슘, 질산칼슘, 염화칼슘, 아세트산칼슘, 산화칼슘, 인산칼슘, 수산화마그네슘, 탄산마그네슘, 황산마그네슘, 아세트산마그네슘, 규산마그네슘, 산화마그네슘, 수산화알루미나마그네슘, 메타규산알루민산마그네슘, 규산알루민산마그네슘, 합성 히드로탈사이트, 및 디히드록시알루미늄아미노아세테이트 등을 들 수 있다. 이들은 1종 단독 또는 2종 이상을 적당히 조합해서 사용할 수 있다. 그 중에서도 점착제층의 전연 공정에 있어서 점착제층이 되는 점착제 조성물을 지지체의 적어도 일면에 균일하게 도포하는 점으로부터 즉효성보다 서서히 작용하는 것(수이용성(水易溶性)보다 수난용성이며 서서히 점착제층에 용해하는 것)이 바람직하다. 이러한 성분으로서는, 예를 들면 수산화알루미나마그네슘, 메타규산알루민산마그네슘, 규산알루민산마그네슘, 합성 히드로탈사이트, 및 디히드록시알루미늄아미노아세테이트가 바람직하다.(D) Component is a polyvalent metal salt, and acts as a crosslinking agent. Examples of polyvalent metal salts include alum such as potassium alum, ammonium alum, iron alum, aluminum hydroxide, aluminum sulfate, aluminum chloride, aluminum acetate, aluminum oxide, aluminum silicate, aluminum metasilicate, calcium hydroxide, calcium carbonate, calcium phosphate, calcium nitrate, calcium chloride. , Calcium acetate, calcium oxide, calcium phosphate, magnesium hydroxide, magnesium carbonate, magnesium sulfate, magnesium acetate, magnesium silicate, magnesium oxide, alumina magnesium hydroxide, magnesium metasilicate, magnesium aluminate, magnesium aluminate, synthetic hydrotalcite, and di And hydroxyaluminum aminoacetate. These can be used alone or in combination of two or more as appropriate. Among them, the pressure-sensitive adhesive composition used as the pressure-sensitive adhesive layer is uniformly applied to at least one surface of the support in the process of leading the pressure-sensitive adhesive layer, so that it acts more slowly than the immediate effect (it is less water soluble than water-soluble, and gradually dissolves in the pressure-sensitive adhesive layer. To do) is preferable. As such a component, for example, magnesium alumina hydroxide, magnesium alumina metasilicate, magnesium aluminate silicate, synthetic hydrotalcite, and dihydroxyaluminum aminoacetate are preferable.
(D)성분의 함유량은 점착제층 중 0.01~2질량%가 바람직하고, 0.03~1질량%가 보다 바람직하고, 0.05~0.5질량%가 더욱 바람직하다. 0.01질량% 이상으로 함으로써 점착제층의 보형성을 보다 충분히 얻을 수 있고, 이면 얼룩이 보다 억제된다. 한편, 2질량% 이하로 함으로써 첩부제의 벗겨짐·말림이 보다 억제되고, 또한 제조 시에 가교 속도의 조정이 용이해지고, 점착제층이 되는 점착제 조성물의 도포 불균일이 억제된다.The content of the component (D) is preferably 0.01 to 2 mass% in the pressure-sensitive adhesive layer, more preferably 0.03 to 1 mass%, and even more preferably 0.05 to 0.5 mass%. By setting it as 0.01 mass% or more, the shape retention of a pressure-sensitive adhesive layer can be obtained more sufficiently, and unevenness on the back surface is more suppressed. On the other hand, when the amount is 2% by mass or less, peeling and curling of the patch is more suppressed, the crosslinking rate is easily adjusted during production, and uneven coating of the pressure-sensitive adhesive composition serving as the pressure-sensitive adhesive layer is suppressed.
[(E)성분][(E) component]
본 발명의 점착제층은 (E) 유효 성분, 청량화제 및 온감 부여로부터 선택되는 1종 이상을 함유할 수 있다. 유효 성분으로서는 스테로이드계 항염증제, 비스테로이드계 항염증제, 생약·정유 성분을 들 수 있다.The pressure-sensitive adhesive layer of the present invention may contain one or more selected from (E) an active ingredient, a refreshing agent, and imparting warmth. As an active ingredient, steroid type anti-inflammatory agent, non-steroid type anti-inflammatory agent, herbal medicine and essential oil ingredient are mentioned.
스테로이드계 항염증제로서는, 예를 들면 암시노이드, 발레르산 프레드니솔론, 발레르산 디플루콜톨론, 발레르산 베타메타손, 아세트산 베타메타손, 아세트산 덱사메타손, 디프로피온산 베타메타손, 덱사메타손, 트리암시놀론아세토니드, 릴시노니드, 히드로코르티손, 피발산 플루메타손, 플로오시노니드, 플루오시놀론아세토니드, 플루오로메톨론, 플루드록시코르티드, 프레드니솔론, 프로피온산 클로베타솔, 프로피온산 베클로메타손, 베타메타손, 메틸프레드니솔론, 메틸프레드니솔론아세테이트, 부티르산 히드로코르티손 등을 들 수 있다. 이들 스테로이드계 항염증제를 배합하는 경우의 함유량은 점착제층 중 0.05~5질량%가 바람직하다.As a steroid-based anti-inflammatory agent, for example, anti-inflammatory drugs are hypokinoids, prednisolone valerate, diflucoltolone valerate, betamethasone valerate, betamethasone acetate, dexamethasone acetate, betamethasone dipropionate, dexamethasone, triamcinolone acetonide, rilcinonide, hydrocoorthione. Flumethasone divergent, fluorosinonide, fluocinolone acetonide, fluorometholone, fludroxycortide, prednisolone, clobetasol propionate, beclomethasone propionate, betamethasone, methylprednisolone, methylprednisolone acetate, butyric acid hydrocolate And the like. The content in the case of blending these steroid-based anti-inflammatory agents is preferably 0.05 to 5% by mass in the pressure-sensitive adhesive layer.
비스테로이드계 항염증제로서는, 예를 들면 록소프로펜, 디클로페낙, 펠비낙, 인도메타신, 살리실산글리콜, 살리실산, 아세틸살리실산(아스피린), 아세트아미노펜, 아미노피린, 안티피린, 옥시펜부타존, 설피린, 이부프로펜, 설린닥, 나프록센, 케토프로펜, 에토페나메이트, 살리실아미드, 트리에탄올아민살리실레이트, 플루페남산, 메클로페남산, 콜히친, 부펙사막, 펜부펜, 디플루니살, 알클로페낙, 페닐부타존, 메페남산, 페노프로펜, 벤다작, 피록시캄, 플루르비프로펜, 잘토프로펜, 에토돌락, 프라노프로펜, 메피리졸, 수프로펜, 글리시르레틴산, 글리시리진산 및 그들의 염, 및 유도체 등을 들 수 있다. 비스테로이드계 항염증제를 배합하는 경우의 함유량은 점착제층 중 0.05~5질량%가 바람직하다.Non-steroidal anti-inflammatory agents include, for example, loxoprofen, diclofenac, felbinac, indomethacin, salicylic acid glycol, salicylic acid, acetylsalicylic acid (aspirin), acetaminophen, aminopyrine, antipyrine, oxyfenbutazone, sulpyrine, ibuprofen. , Sulindac, naproxen, ketoprofen, etofenamate, salicylamide, triethanolamine salicylate, flufenamic acid, meclofenamic acid, colchicine, bupexamak, fenbufen, diflunisal, alclofenac, phenyl Butazone, mefenamic acid, fenoprofen, bendazac, piroxicam, flurbiprofen, zaltoprofen, etodolac, pranoprofen, mepyrazole, suprofen, glycyrrhetinic acid, glycyrrhizic acid and And their salts and derivatives. The content of the non-steroidal anti-inflammatory agent is preferably 0.05 to 5% by mass in the pressure-sensitive adhesive layer.
생약·정유 성분으로서는, 예를 들면 보리 등의 생약가루나, 황백, 산초나무, 당약, 감초, 황금, 치자, 당귀, 딱총나무, 양매피, 율무쌀 등의 생약 추출물, 박하유, 박하백유, 계피유 등의 정유 등을 들 수 있다. 생약이나 정유 성분을 배합하는 경우의 함유량은 점착제층 중 0.05~5질량%가 바람직하다.As a herbal medicine/essential oil component, for example, herbal medicine powder such as barley, Hwangbaek, Japanese pepper tree, sugar medicine, licorice, golden, gardenia, angelica, elderberry, yangmaepi, extracts of herbal medicines such as barley, mentha oil, mint white oil, cinnamon oil, etc. And essential oils. In the case of blending the herbal medicine or essential oil component, the content is preferably 0.05 to 5% by mass in the pressure-sensitive adhesive layer.
청량화제로서는, 예를 들면 리모넨, 테르피놀렌, 메탄, 테르피넨 등의 p-메탄 및 그들로부터 유도되는 단환식 모노테르펜계 탄화수소 화합물 등의 테르펜계 탄화수소 화합물, l-멘톨, 이소푸레골, 1,3-메톡시프로판-1,2-디올 등의 멘톨 유연(類緣) 화합물, 캄퍼, 티몰 등이 적합하게 사용된다. 청량화제를 배합하는 경우의 함유량은 점착제층 중 0.05~5질량%가 바람직하다.Examples of the refreshing agent include p-methane such as limonene, terpinolene, methane, and terpinene, and terpene-based hydrocarbon compounds such as monocyclic monoterpene-based hydrocarbon compounds derived therefrom, l-menthol, isopuregol, 1 Menthol related (類緣) compounds such as ,3-methoxypropane-1,2-diol, camphor, thymol, and the like are suitably used. The content in the case of blending a refreshing agent is preferably 0.05 to 5% by mass in the pressure-sensitive adhesive layer.
온감 부여제로서는 피부에 적용했을 시에 온감을 느끼게 하는 물질이면 좋고, 이러한 물질로서, 예를 들면 캡시코시드, 캡사이신, 캡사이시노이드, 디히드록시캡사이신, 캡산틴 등의 캡사이신 유사체, 고추 추출물, 고추 틴크, 고추가루 등의 고추 유래의 온감 부여 물질, 니코틴산벤질, 니코틴산 β-부톡시에틸, N-아실와닐아미드, 노닐산와닐아미드, 바닐릴부틸에테르, 아세트산토코페롤, 아세틸유게놀, 연명초 추출물, 목탄피 추출물, 아르니카 틴크, 생강 추출물, 계피유 등을 들 수 있다. 온감 부여제를 배합하는 경우의 함유량은 점착제층 중 0.05~5질량%가 바람직하다.As the warmth imparting agent, any material that makes the feeling of warmth when applied to the skin may be used.For example, capsaicin analogues such as capsicoside, capsaicin, capsaicinoid, dihydroxycapsaicin, and capxanthin, pepper extract , Red pepper tink, red pepper powder, etc., benzyl nicotinate, β-butoxyethyl nicotinic acid, N-acylwanilamide, nonylic acid vanilamide, vanillyl butyl ether, tocopherol acetate, acetyleugenol, jointed herb Extract, charcoal extract, arnica tincture, ginger extract, cinnamon oil, and the like. The content in the case of blending the warmth imparting agent is preferably 0.05 to 5% by mass in the pressure-sensitive adhesive layer.
이들 (E)성분 중 본 발명에서는 록소프로펜나트륨, 디클로페낙나트륨, 펠비낙, 인도메타신, 살리실산글리콜, l-멘톨, 고추 추출물, 박하백유가 바람직하다.Among these (E) components, in the present invention, loxopropene sodium, diclofenac sodium, felbinac, indomethacin, salicylic acid glycol, l-menthol, red pepper extract, and white peppermint are preferred.
(E)성분을 배합하는 경우의 함유량은 유효량으로 좋지만, 점착제층 중 0.05~5질량%가 바람직하고, 0.2~2질량%가 보다 바람직하다. 0.05질량% 이상으로 함으로써 충분한 약효나 청량감, 온감이 얻어진다. 5질량%를 초과하여 배합해도 한층 높은 약효나 청량감, 온감은 얻어지지 않고 피부 자극이 생길 가능성이 있다.The content in the case of blending the component (E) is good in an effective amount, but 0.05 to 5 mass% in the pressure-sensitive adhesive layer is preferred, and 0.2 to 2 mass% is more preferred. By setting it as 0.05 mass% or more, sufficient medicinal effect, a feeling of refreshment, and a feeling of warmth are obtained. Even if it is blended in excess of 5% by mass, a higher medicinal effect, refreshing sensation, and warm sensation cannot be obtained, and skin irritation may occur.
[임의 성분][Optional ingredient]
본 발명의 점착제층에는 본 발명의 효과를 손상시키지 않는 범위에서 일반적으로 함수 점착제에 사용되고 있는 하기 성분을 각각 1종 단독으로 또는 2종 이상을 적당히 조합해서 적당량 사용할 수 있다. 또한, 하기 성분은 예시이며, 성분에 따라서는 중복해서 기재되는 경우도 있다.In the pressure-sensitive adhesive layer of the present invention, an appropriate amount of the following components generally used for a water-containing pressure-sensitive adhesive may be used alone or in an appropriate combination of two or more, within a range not impairing the effects of the present invention. In addition, the following components are examples, and depending on the components, they may be repeatedly described.
(1) 경화 조정제(1) hardening modifier
에데트산나트륨, 에데트산나트륨 수화물, 메타인산나트륨, 시트르산 등을 사용할 수 있다. 경화 조정제를 배합하는 경우의 함유량은 점착제층 중 0.01~3질량%가 바람직하다.Sodium edetate, sodium edetate hydrate, sodium metaphosphate, citric acid, and the like can be used. The content in the case of blending the curing modifier is preferably 0.01 to 3% by mass in the pressure-sensitive adhesive layer.
(2) 유기산(2) organic acid
주석산, 말산, 락트산 등을 들 수 있다. 유기산을 배합하는 경우의 함유량은 점착제층 중 0.1~3질량%가 바람직하다.Tartaric acid, malic acid, and lactic acid. The content in the case of blending an organic acid is preferably 0.1 to 3% by mass in the pressure-sensitive adhesive layer.
(3) 방부제(3) preservative
파라옥시벤조산메틸(메틸파라벤), 파라옥시벤조산프로필(프로필파라벤) 등을 들 수 있다. 방부제를 배합하는 경우의 함유량은 점착제층 중 0.01~2질량%가 바람직하다.Methyl paraoxybenzoate (methylparaben), propyl paraoxybenzoate (propylparaben), and the like. The content in the case of blending a preservative is preferably 0.01 to 2% by mass in the pressure-sensitive adhesive layer.
(4) 유화제(계면활성제)(4) emulsifier (surfactant)
폴리옥시에틸렌 경화 피마자유, 폴리옥시에틸렌(20) 소르비탄 모노올리에이트(폴리소르베이트80) 등의 폴리옥시에틸렌 소르비탄 지방산 에스테르, 폴리옥시에틸렌글리세린 지방산 에스테르, 폴리옥시에틸렌글리콜 지방산 에스테르, 폴리옥시에틸렌글리콜에테르, 폴리옥시에틸렌알킬페닐에테르, 폴리옥시에틸렌폴리옥시프로필렌알킬에테르, 폴리옥시에틸렌피토스테롤, 소르비탄 지방산 에스테르, 글리세린 지방산 에스테르 등을 들 수 있다. 계면활성제를 배합하는 경우의 함유량은 점착제층 중 0.2~5.0질량%가 바람직하다.Polyoxyethylene sorbitan fatty acid ester such as polyoxyethylene hydrogenated castor oil, polyoxyethylene (20) sorbitan monooleate (polysorbate 80), polyoxyethylene glycerin fatty acid ester, polyoxyethylene glycol fatty acid ester, polyoxy Ethylene glycol ether, polyoxyethylene alkylphenyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene phytosterol, sorbitan fatty acid ester, glycerin fatty acid ester, and the like. The content in the case of blending a surfactant is preferably 0.2 to 5.0% by mass in the pressure-sensitive adhesive layer.
(5) 향료(5) fragrance
회향유, 대회향유, 클로브유, 티미유, 테레빈유, 헤노포디유, 야마진유, 유킬립툽스유, 라벤더유. 페퍼민트유, 레몬유, 오렌지유, 등화유, 베르가모트유, 로즈유, 시트로넬라유, 레몬그라스유, 캄퍼유, 제라늄유, 로즈마리유, 세이지유 등을 들 수 있다. 또한, 식물 추출물로서는, 예를 들면 알로에, 아니스, 안젤리카, 안식향, 이모텔, 카밀레, 카모마일, 갈릭, 카다몬, 갈바넘, 캐러웨이, 캐롯 시드, 유창목, 그레이프프루트, 사이프레스, 샌달우드, 시더우드, 주니퍼, 스타아니스, 세이지, 제라늄, 셀러리, 타임, 타라곤, 테레빈, 유향, 바이올렛, 파인, 파슬리, 버치, 파촐리, 로즈, 히솝, 펜넬, 블랙페퍼, 보리수화, 몰약, 서양톱풀, 레몬, 레몬그라스, 로즈마리, 월계수, 조팝나무국화, 조팝나무풀, 수레국화, 아몬드, 엉겅퀴, 아르니카, 사이프러스, 회향, 금작화, 에리카, 목향, 겨자, 괄루근, 감수, 국화씀바귀, 우산잔디, 금잔화, 애기똥풀, 물냉이, 진달래, 겐티아나, 체리, 차전자, 자작나무, 시더, 질려자, 장뇌, 자리공, 큰잎용담, 자두, 배, 정금나무, 대추, 택사, 민들레, 지모, 처빌, 저령, 아스파라거스 뿌리, 동과자, 찔레꽃, 야생 당근, 아케밀라, 물푸레나무, 자주광대나물, 애기수영, 복령, 보리지, 머그워트, 마요라나, 멜리사, 목통, 복숭아, 겨우살이, 유칼립투스, 라벤더, 개나리, 겨자무 등으로부터의 추출물을 들 수 있다. 이들 중에서도 특히 카모마일, 세이지, 파슬리, 로즈마리, 조팝나무국화, 조팝나무풀, 수레국화, 아니스, 월계수, 안젤리카, 펜넬, 페퍼민트, 레몬밤, 라벤더, 타임 등으로부터의 추출물이 적합하다. 이러한 추출물의 구체적인 성분으로서, 예를 들면 시네올, 보르네올, 그 외에 캄퍼(장뇌), 리난올, 베르베놀, 플라보노이드류, 콜린, 아미노산, 탄닌, 식물산, 지방산, 청산배당체, 살빈, 축합 탄닌, 페놀산, 카르노스산, 트리테르펜산, 투욘, 살벤, 피넨, 아피올, 아피올린, 미리스트산, 쿠마린, 카마쥴렌, 파르네센, 비사보롤, 게라니올, 오이게놀, 테르펜, 펠란드렌, 아네톨, 멘톤, 시트랄, 시트로넬랄, 오이게놀아세테이트 등을 들 수 있다. 향료를 배합하는 경우의 함유량은 점착제층 중 0.01~1질량%가 바람직하다.Fennel oil, big oil, clove oil, thyme oil, turpentine oil, henopodilla oil, yamajin oil, oil lip tops oil, lavender oil. Peppermint oil, lemon oil, orange oil, lantern oil, bergamot oil, rose oil, citronella oil, lemongrass oil, camphor oil, geranium oil, rosemary oil, sage oil, and the like. In addition, as a plant extract, for example, aloe, anise, angelica, benzoin, imoteel, chamomile, chamomile, garlic, cardamom, galvanum, caraway, carrot seed, rapeseed, grapefruit, cypress, sandalwood, cedarwood , Juniper, star anise, sage, geranium, celery, thyme, tarragon, turpentine, frankincense, violet, pine, parsley, birch, patchouli, rose, hyssop, fennel, black pepper, bodhi, myrrh, yarrow, lemon, Lemongrass, rosemary, laurel tree, spirea chrysanthemum, spirea, cornflower, almond, thistle, arnica, cypress, fennel, marigold, Erica, locust, mustard, gorilla root, persimmon tree, chrysanthemum grass, umbrella grass, marigold, celandine , Watercress, rhododendron, gentiana, cherry, tea plantation, birch, cedar, boredom, camphor, jujube, large leaf gentian, plum, pear, golden tree, jujube, texas, dandelion, jimo, chervil, jeeryeong, asparagus root , Winter sweets, brier flowers, wild carrots, akemila, ash tree, purple purple sprouts, baby swimming, bokryeong, borage, mugwort, marjoram, melissa, neck barrel, peach, mistletoe, eucalyptus, lavender, forsythia, mustard radish, etc. And extracts of. Among these, extracts from chamomile, sage, parsley, rosemary, spirea chrysanthemum, spirea grass, cornflower, anise, laurel, angelica, fennel, peppermint, lemon balm, lavender, thyme, and the like are particularly suitable. Specific components of such an extract include, for example, cineol, borneol, and other camphor (camper), linanol, berbenol, flavonoids, choline, amino acids, tannins, vegetable acids, fatty acids, cyanoglycosides, salbins, condensed tannins, Phenolic acid, carnosic acid, triterpenic acid, tuyon, salben, pinene, apiol, apiolin, myristic acid, coumarin, camazulene, farnesene, bisabolol, geraniol, oigenol, terpene, phelland Ren, anetol, menthone, citral, citronellal, and eugenol acetate. The content in the case of blending the fragrance is preferably 0.01 to 1% by mass in the pressure-sensitive adhesive layer.
(6) 색소(6) pigment
적색 2호, 적색 3호, 적색 102호, 적색 104호, 적색 105호, 적색 106호, 적색 201호, 적색 202호, 적색 203호, 적색 204호, 적색 205호, 적색 206호, 적색 207호, 적색 208호, 적색 213호, 적색 214호, 적색 215호, 적색 218호, 적색 219호, 적색 220호, 적색 221호, 적색 223호, 적색 225호, 적색 226호, 적색 227호, 적색 228호, 적색 230호의 (1), 적색 230호의 (2), 적색 231호, 적색 232호, 적색 401호, 적색 404호, 적색 405호, 적색 501호, 적색 502호, 적색 503호, 적색 504호, 적색 505호, 적색 506호, 황색 4호, 황색 5호, 황색 201호, 황색 202호의 (1), 황색 202호의 (2), 황색 203호, 황색 204호, 황색 205호, 황색 401호, 황색 402호, 황색 403호의 (1), 황색 404호, 황색 405호, 황색 406호, 황색 407호, 녹색 3호, 녹색 201호, 녹색 202호, 녹색 204호, 녹색 205호, 녹색 401호, 녹색 402호, 청색 1호, 청색 2호, 청색 201호, 청색 202호, 청색 203호, 청색 204호, 청색 205호, 청색 401호, 청색 403호, 청색 404호, 등색 201호, 등색 203호, 등색 204호, 등색 205호, 등색 206호, 등색 207호, 등색 401호, 등색 402호, 등색 403호, 갈색 201호, 자색 201호, 자색 401호, 흑색 401호 등을 들 수 있다. 색소의 함유량은 특별히 제한은 없고, 목적에 따라 적당히 선택할 수 있지만, 색소를 배합하는 경우의 함유량은 점착제층 중 0.00005~0.1질량%가 바람직하고, 0.0001~0.01질량%가 보다 바람직하다. 함유량이 지나치게 적으면 배합에 의한 효과가 충분히 얻어지지 않을 우려가 있으며, 지나치게 많으면 색조가 지나치게 강해질 우려가 있다. 또한, 색소를 배합하는 경우, 점착제 조성물을 지지체의 표면에 전연했을 때에 색소의 농담이나 반점이 생기지 않도록 색소를 물, 유지, 알코올 등에 녹인 후에, 타성분과 반죽하는 것이 바람직하다.Red No. 2, Red No. 3, Red No. 102, Red No. 104, Red No. 105, Red No. 106, Red No. 201, Red No. 202, Red No. 203, Red No. 204, Red No. 205, Red No. 206, Red No. 207 Red No.208, Red No.213, Red No.214, Red No.215, Red No.218, Red No.219, Red No.220, Red No.221, Red No.223, Red No.225, Red No.226, Red No.227, Red No.228, Red No.230 (1), Red No.230 (2), Red No.231, Red No.232, Red No.401, Red No.404, Red No.405, Red No.501, Red No.502, Red No.503, Red No.504, Red No.505, Red No.506, Yellow No.4, Yellow No.5, Yellow No.201, Yellow No.202 (1), Yellow No.202 (2), Yellow No.203, Yellow No.204, Yellow No.205, Yellow No.401, Yellow No.402, Yellow No.403 (1), Yellow No.404, Yellow No.405, Yellow No.406, Yellow No.407, Green No.3, Green No.201, Green No.202, Green No.204, Green No.205 , Green No.401, Green No.402, Blue No.1, Blue No.2, Blue No.201, Blue No.202, Blue No.203, Blue No.204, Blue No.205, Blue No.401, Blue No.403, Blue No.404, Orange 201, Orange 203, Orange 204, Orange 205, Orange 206, Orange 207, Orange 401, Orange 402, Orange 403, Brown 201, Purple 201, Purple 401, Black 401 And the like. The content of the dye is not particularly limited and can be appropriately selected depending on the purpose, but the content in the case of blending the dye is preferably 0.00005 to 0.1% by mass, and more preferably 0.0001 to 0.01% by mass in the pressure-sensitive adhesive layer. If the content is too small, there is a fear that the effect due to the blending may not be sufficiently obtained, and if it is too large, the color tone may become too strong. In addition, in the case of blending a dye, it is preferable to dissolve the dye with water, fat or oil, alcohol, etc., and then knead it with other ingredients so that when the pressure-sensitive adhesive composition is spread on the surface of the support, so as not to cause shades or spots of the dye.
점착제층의 함수량은 점착제층 중 70질량% 이상이며, 70~82질량%가 바람직하다. 함수율을 70질량% 이상으로 함으로써 충분한 냉각 효과가 얻어지고, 82질량% 이하로 함으로써 이면 얼룩이 억제된다.The water content of the pressure-sensitive adhesive layer is 70% by mass or more in the pressure-sensitive adhesive layer, and preferably 70 to 82% by mass. When the water content is 70% by mass or more, a sufficient cooling effect is obtained, and when the content is 82% by mass or less, unevenness on the back side is suppressed.
점착제층의 pH는 3.5~6이 바람직하고, 4~5가 보다 바람직하고, 4.2~4.7이 더욱 바람직하다. pH의 측정은 25℃의 조건 하에서 지지체에 전연한 후의 점착제 조성물에 pH 미터(예를 들면, DKK-TOA CORPORATION제의 HM-30V, 플랫형 pH 전극 GST-5313F)를 접촉시켜서 측정한다.The pH of the pressure-sensitive adhesive layer is preferably 3.5 to 6, more preferably 4 to 5, and even more preferably 4.2 to 4.7. The pH is measured by bringing a pH meter (for example, HM-30V manufactured by DKK-TOA CORPORATION, flat pH electrode GST-5313F) into contact with the pressure-sensitive adhesive composition after spreading to the support under the conditions of 25°C.
(ii) 점착제층의 제조 방법(ii) Method for producing an adhesive layer
점착제층의 제조 방법으로서는 특별히 한정되지 않지만, (A) 및 (B)성분의 불용해 응집물을 보다 생기기 어렵게 하는 점으로부터 예를 들면, (A) 폴리아크릴산 및 그 염으로부터 선택되는 1종 이상과, (B) 셀룰로오스 유도체를 (C) 다가 알코올에 분산시키는 공정을 포함하는 것이 바람직하다. Although it does not specifically limit as a manufacturing method of an adhesive layer, From the point which makes insoluble aggregate of (A) and (B) component more difficult to generate|occur|produce, For example, (A) one or more types selected from polyacrylic acid and its salt, and, It is preferable to include the step of dispersing (B) a cellulose derivative in (C) polyhydric alcohol.
보다 구체적으로는 (C) 다가 알코올에 분말 형상의 (A) 폴리아크릴산 및 그 염으로부터 선택되는 1종 이상과, (B) 셀룰로오스 유도체를 첨가하고, (A) 및 (B)성분을 분산시키고 교반하여 예비 분산물 1을 제작한다. 별도, (D)성분을 (C)성분에 분산시켜 예비 분산물 2를 제작하는 공정을 포함한다. (E)성분은 예비 분산물에 분산시켜도 좋지만, 향료나 방부제와 함께 유화제에 혼합하는 공정을 포함하는 것이 바람직하다. 물에 그 외의 임의 성분을 혼합한 예비 혼합물에 예비 분산물 1을 첨가하고 교반한 후에 예비 분산물 2를 첨가하고 교반하는 공정을 포함하는 것이 바람직하다. 임의 성분은 각각 예비 용해물, 예비 분산물로서 첨가해도 좋다.More specifically, (C) at least one selected from powdery (A) polyacrylic acid and salts thereof, and (B) a cellulose derivative are added to a polyhydric alcohol, and the components (A) and (B) are dispersed and stirred. To prepare pre-dispersion 1. Separately, a step of dispersing the component (D) in the component (C) to prepare a pre-dispersion 2 is included. The component (E) may be dispersed in a pre-dispersion, but it is preferable to include a step of mixing the emulsifier together with a fragrance or preservative. It is preferable to include a step of adding and stirring the pre-dispersion 2 after adding and stirring the pre-dispersion 1 to the pre-mixture in which water and other optional components are mixed. Optional components may be added as a pre-dissolved product and a pre-dispersion, respectively.
(iii) 지지체(iii) support
지지체로서는 공지의 것을 사용할 수 있고, 예를 들면 종이, 직포, 부직포, 편성포를 들 수 있다. 그 중에서도 평량 90~140g/㎡의 편성포 또는 평량 70~140g/㎡의 부직포가 바람직하다. 점착제층이 되는 점착제 조성물을 지지체에 전연할 때의 전연량은 특별히 제한되는 것은 아니지만, 지지체 1㎡당 800~1,200g이 바람직하다.Known things can be used as the support, and examples thereof include paper, woven fabric, nonwoven fabric, and knitted fabric. Among them, a knitted fabric having a basis weight of 90 to 140 g/m2 or a nonwoven fabric having a basis weight of 70 to 140 g/m2 is preferable. The amount of leading edge when leading the pressure-sensitive adhesive composition serving as the pressure-sensitive adhesive layer to the support is not particularly limited, but is preferably 800 to 1,200 g per 1 m 2 of the support.
편성포로서는 섬유의 소재(종류)는 특별히 한정되지 않고, 예를 들면 폴리에스테르, 나일론, 폴리올레핀(PE, PP 등), 비닐론, 폴리염화비닐리덴, 폴리염화비닐, 아크릴 수지, 폴리우레탄 등의 수지류를 들 수 있다. 또한, 이들의 중합도는 특별히 제한되는 것은 아니고, 편성포의 소재로서 통상 사용되고 있는 중합도의 것을 사용할 수 있다.The material (type) of the fiber is not particularly limited as the knitted fabric, and for example, polyester, nylon, polyolefin (PE, PP, etc.), vinylon, polyvinylidene chloride, polyvinyl chloride, acrylic resin, polyurethane, etc. Tributaries are mentioned. In addition, the degree of polymerization of these is not particularly limited, and those of the degree of polymerization that are usually used as a material for a knitted fabric can be used.
편성포의 편성 방법은 특별히 제한되는 것은 아니고, 예를 들면 경편성(트리코트 편성, 덴비트리코트 편성, 새틴 편성, 아틀라스 편성, 평편성, 림 편성, 펄 편성), 환편성(양면 메리야스 편성, 편면 메리야스 편성, 원형 리브 메리야스 편성), 횡편성, 멀티필라멘트사에 의해 편성된 환편성, 복수단의 양면 메리야스 편성, 니트미스 편성, 크로스 인레이 편성, 인레이 편성 등이 채용된다. 바람직하게는, 트리코트 편성, 양면 메리야스 편성, 편면 메리야스 편성, 원형 리브 메리야스 편성, 멀티필라멘트사에 의해 편성된 환편성, 복수단의 양면 메리야스 편성이 채용된다. 편성포에 사용하는 섬유는 단사를 사용하는 경우는 일반적으로 10~80데니어를 사용할 수 있다. 멀티필라멘트를 사용하는 경우는 일반적으로 40~100데니어의 섬유를 사용할 수 있다.The knitting method of the knitted fabric is not particularly limited, and for example, warp knitting (tricoat knitting, denvitricoat knitting, satin knitting, atlas knitting, flat knitting, rim knitting, pearl knitting), circular knitting (double-sided meriyasu knitting, Single-sided yarn knitting, circular rib yarn knitting), horizontal knitting, circular knitting knitted by multifilament yarn, double-sided yarn knitting in multiple stages, knit miss knitting, cross inlay knitting, inlay knitting, etc. are employed. Preferably, tricot knitting, double-sided yarn knitting, single-sided yarn knitting, circular rib yarn knitting, circular knitting knitted by multifilament yarn, and multiple stages of double-sided yarn knitting are preferably employed. In the case of using single yarn, the fiber used for the knitted fabric can be generally 10 to 80 denier. When multifilament is used, fibers of 40 to 100 denier can be used in general.
편성포의 평량은 90~140g/㎡가 바람직하고, 하한은 95g/㎡ 이상이 보다 바람직하고, 100g/㎡ 이상이 더욱 바람직하다. 평량이 90g/㎡ 미만이면, 꼬임도가 약해지고, 전연 시 점착제층에 뭉침, 늘어짐이 생길 우려가 있다. 상한은 130g/㎡ 이하가 바람직하고, 120g/㎡ 이하가 보다 바람직하다. 평량이 140g/㎡를 초과하면, 점착제층이 단단해져 피부에의 추종성 등의 사용감이 나빠질 우려가 있다.The basis weight of the knitted fabric is preferably 90 to 140 g/m 2, the lower limit is more preferably 95 g/m 2 or more, and even more preferably 100 g/m 2 or more. If the basis weight is less than 90g/m2, the degree of twisting is weakened, and there is a concern that agglomeration and sagging may occur in the pressure-sensitive adhesive layer during leading edge. The upper limit is preferably 130 g/m 2 or less, and more preferably 120 g/m 2 or less. If the basis weight exceeds 140 g/m 2, there is a fear that the pressure-sensitive adhesive layer becomes hard and the feeling of use, such as conformability to the skin, is deteriorated.
부직포로서 섬유의 소재는 특별히 한정되지 않고, 예를 들면 폴리아미드, 폴리에틸렌, 폴리에틸렌테레프탈레이트 등의 폴리에스테르계 수지, 폴리프로필렌 등의 폴리올레핀계 수지, 폴리에스테르에테르, 폴리우레탄계 수지, 아크릴계 수지, 폴리비닐알코올, 폴리스티렌계 수지 등을 들 수 있다.As a nonwoven fabric, the material of the fiber is not particularly limited, and for example, polyester resins such as polyamide, polyethylene, polyethylene terephthalate, polyolefin resins such as polypropylene, polyester ether, polyurethane resin, acrylic resin, polyvinyl Alcohol, polystyrene resin, etc. are mentioned.
제법으로서는 특별히 한정되지 않고, 스펀레이스, 스펀본드, 서멀 본드, 케미컬 본드, 니들 펀치 등의 제법에 의한 부직포가 선택된다.The manufacturing method is not particularly limited, and a nonwoven fabric by a manufacturing method such as spunlace, spunbond, thermal bond, chemical bond, and needle punch is selected.
부직포의 평량은 70~140g/㎡가 바람직하고, 하한은 75g/㎡ 이상이 바람직하고, 80g/㎡ 이상이 보다 바람직하다. 평량이 70g/㎡ 미만이면, 꼬임도가 약해지고, 전연 시 점착제층에 뭉침, 늘어짐이 생길 우려가 있다. 상한은 130g/㎡ 이하가 바람직하고, 120g/㎡ 이하가 보다 바람직하다. 평량이 140g/㎡를 초과하면, 점착제층이 단단해져 피부에의 추종성 등의 사용감이 나빠질 우려가 있다.The basis weight of the nonwoven fabric is preferably 70 to 140 g/m 2, the lower limit is preferably 75 g/m 2 or more, and more preferably 80 g/m 2 or more. If the basis weight is less than 70g/m2, the degree of twisting is weakened, and there is a concern that agglomeration and sagging may occur in the pressure-sensitive adhesive layer during leading edge. The upper limit is preferably 130 g/m 2 or less, and more preferably 120 g/m 2 or less. If the basis weight exceeds 140 g/m 2, there is a fear that the pressure-sensitive adhesive layer becomes hard and the feeling of use, such as conformability to the skin, is deteriorated.
(iv) 첩부제 및 그 제조 방법(iv) patch and its manufacturing method
본 발명의 첩부제는 함수율은 70질량% 이상의 점착제층과 지지체를 구비한 것이다. 예를 들면, 지지체의 편면에 점착제층이 형성된다. 점착제층이 되는 점착제 조성물을 지지체에 전연한 후, 필요에 따라 폴리에틸렌, 폴리프로필렌, 폴리에틸렌테레프탈레이트 등의 플라스틱 필름(박리 라이너)을 사용하여 점착제층의 표면을 덮고, 소망의 크기로 재단해서 사용할 수 있다. 또는, 박리 라이너에 점착제층이 되는 점착제 조성물을 전연한 후에 이것을 지지체에 첩합하고, 소망의 크기로 재단해서 사용할 수 있다.The patch of the present invention comprises an adhesive layer and a support having a water content of 70% by mass or more. For example, an adhesive layer is formed on one side of the support. After spreading the pressure-sensitive adhesive composition that becomes the pressure-sensitive adhesive layer on the support, if necessary, the surface of the pressure-sensitive adhesive layer is covered with a plastic film (release liner) such as polyethylene, polypropylene, and polyethylene terephthalate, and cut to the desired size. have. Alternatively, after spreading the pressure-sensitive adhesive composition serving as the pressure-sensitive adhesive layer on the release liner, this may be bonded to a support, and cut to a desired size.
점착제층의 볼택값에 의한 점착력은 10~32인 것이 바람직하고, 16~30이 보다 바람직하다. 하한 이상으로 함으로써 점착력이 향상되어 첩부제의 벗겨짐·말림을 보다 억제할 수 있다. 한편, 상한 이하로 함으로써 피부 자극이나 벗길 때의 통증이 적어진다. 또한, 볼택에 의한 점착력의 측정 방법은 JIS Z 0237에 기재된 방법에 준하여 측정한다. 구체적으로는 JIS Z 0237에서 사용되고 있는 볼 굴림 장치를 사용하고, 경사각을 30°, 조주로의 길이를 100mm, 측정하는 면을 50mm로 한다. JIS G 4805에서 규정되어 있는 재질의 볼을 사용하고, 볼의 크기는 JIS B 1501의 「볼의 호칭 치수」의 1/16으로부터 1까지의 합계 31종류로서 「볼의 호칭 치수」의 32배의 수치를 볼 넘버로 해서 점착력의 지표로서 사용한다. 볼 굴림 장치의 경사판 상의 소정의 위치에 점착면을 위로 해서 시험편을 부착하고, 각 크기의 볼을 게이트에 세팅한다. 게이트를 서서히 열어서 볼을 굴려 측정면 내에서 완전히 정지하는(5초 이상 움직이지 않는) 볼 중 최대의 것을 찾아내어 그 볼 넘버를 볼택값으로 한다.It is preferable that it is 10-32, and, as for the adhesive force by the vortex value of an adhesive layer, 16-30 are more preferable. By setting it as more than the lower limit, adhesive force is improved and peeling and curling of a patch can be suppressed more. On the other hand, by making it below the upper limit, skin irritation and pain at the time of peeling are reduced. In addition, the measuring method of the adhesive force by a vortex is measured according to the method described in JIS Z 0237. Specifically, a ball rolling device used in JIS Z 0237 is used, the inclination angle is 30°, the length of the runway is 100 mm, and the surface to be measured is 50 mm. Balls made of the material specified in JIS G 4805 are used, and the size of the balls is 31 types in total from 1/16 to 1 of the "Nominal Dimensions of Balls" of JIS B 1501, which is 32 times the "nominal dimensions of balls". Use the numerical value as the ball number as an index of adhesion. A test piece is attached to a predetermined position on the inclined plate of the ball rolling device with the adhesive surface facing up, and balls of each size are set on the gate. Open the gate slowly, roll the ball, find the largest ball that stops completely within the measuring surface (does not move for more than 5 seconds), and uses the ball number as the voltaic value.
본 발명의 첩부제의 사용 방법은 특별히 한정되지 않고, 예를 들면 인간의 어깨, 허리, 장딴지, 넓적다리나 발바닥 등에 첩부제를 첩부하여 사용한다.The method of using the patch of the present invention is not particularly limited, and for example, the patch is applied to the shoulder, waist, calf, thigh or sole of a human being used.
실시예Example
이하, 실시예 및 비교예를 나타내어 본 발명을 구체적으로 설명하지만, 본 발명은 하기 실시예에 제한되는 것은 아니다. 또한, 하기 예에 있어서 특별히 명기가 없는 경우는 조성의 「%」는 질량%, 비율은 질량비를 나타낸다.Hereinafter, examples and comparative examples are shown to specifically describe the present invention, but the present invention is not limited to the following examples. In addition, in the following examples, when there is no particular indication, "%" of a composition represents mass %, and a ratio represents a mass ratio.
[실시예, 비교예][Examples, Comparative Examples]
<제조 방법><Production method>
정제수에 에데트산나트륨 수화물을 교반하면서 첨가하여 (예비 용해물 1)을 얻었다. 정제수에 메타인산나트륨 또는 시트르산을 교반하면서 첨가하여 (예비 용해물 2)를 얻었다. 정제수에 주석산, 말산 또는 락트산을 교반하면서 첨가하여 (예비 용해물 3)을 얻었다. 유화제에 (E)성분, l-멘톨, 방부제, 향료를 첨가하여 교반함으로써 (예비 혼합물 1)을 얻었다. 일부의 (C)성분에 분말 형상의 (A)성분 및 (B)성분을 첨가하여 교반하고, 이들을 균일하게 분산·용해시켜 (예비 분산물 1)을 얻었다. 일부의 (C)성분에 (D)성분을 첨가하고 교반하여 (예비 분산물 2)를 얻었다. 나머지의 (C)성분에 색소를 첨가하고 교반하여 (예비 분산물 3)을 얻었다. Sodium edetate hydrate was added to purified water while stirring to obtain (pre-dissolved product 1). Sodium metaphosphate or citric acid was added to purified water while stirring to obtain (pre-lysate 2). Tartaric acid, malic acid, or lactic acid was added to purified water while stirring to obtain (pre-dissolved product 3). (Preliminary mixture 1) was obtained by adding and stirring (E) component, 1-menthol, preservative, and fragrance to an emulsifier. Powdered (A) component and (B) component were added to some (C) components and stirred, and these were uniformly dispersed and dissolved to obtain (pre-dispersion 1). (D) component was added and stirred to some (C) component, and (pre-dispersion 2) was obtained. A dye was added to the remaining (C) component and stirred to obtain (pre-dispersion 3).
예비 용해물 1에 예비 용해물 2, 예비 분산물 3을 첨가하고 헨셀 믹서로 교반하여 (반죽물 1)을 얻었다. Pre-lysate 2 and pre-dispersion 3 were added to the pre-lysed product 1, and stirred with a Henschel mixer to obtain (kneaded product 1).
반죽물 1에 예비 분산물 1을 헨셀 믹서에 교반 투입하고 반죽하여 (반죽물 2)를 얻었다. To the dough 1, the pre-dispersion 1 was stirred into a Henschel mixer and kneaded to obtain (kneaded product 2).
반죽물 2에 예비 분산물 2을 첨가하고 헨셀 믹서로 교반하여 (반죽물 3)을 얻었다. The pre-dispersion 2 was added to the dough 2 and stirred with a Henschel mixer to obtain (dough 3).
반죽물 3에 예비 용해물 3, 예비 용해물 1을 첨가하고 헨셀 믹서로 교반함으로써 점착제 조성물을 얻었다.The pre-dissolved product 3 and the pre-dissolved product 1 were added to the dough 3 and stirred with a Henschel mixer to obtain a pressure-sensitive adhesive composition.
박리 라이너 상에 첩부제 1매당(14cm×10cm)의 점착제층이 약 12g이 되도록 점착제 조성물을 균일하게 전연했다. 그 후, 점착제층의 표면에 폴리에스테르제의 편성포(「평량 105±10g/㎡, 두께 0.70mm, 굵기 75데니어」(Teijin Frontier Co., Ltd.제))를 맞붙이고, 소망의 크기(14cm×10cm)로 재단하여 첩부제를 조제했다. 얻어진 첩부제에 대하여 하기 평가를 행했다. 또한, 실시예에서 얻어진 첩부제의 볼택값에 의한 점착력은 10~32이었다.The pressure-sensitive adhesive composition was spread uniformly on the release liner so that the pressure-sensitive adhesive layer per sheet (14 cm x 10 cm) was about 12 g. Thereafter, a polyester knitted fabric ("base weight 105±10g/m2, thickness 0.70mm, thickness 75 denier" (manufactured by Teijin Frontier Co., Ltd.)) was affixed to the surface of the pressure-sensitive adhesive layer, and the desired size (manufactured by Teijin Frontier Co., Ltd.) was pasted. 14 cm x 10 cm) to prepare a patch. The following evaluation was performed about the obtained patch. In addition, the adhesive strength by the vortex value of the patch obtained in Examples was 10 to 32.
[불용해 응집물 발생률의 평가][Evaluation of insoluble aggregate incidence rate]
불용해 응집물 발생률로서 반죽에 의해 얻어진 점착제 조성물의 전연 중의 샘플링(12g/14cm×10cm의 제제를 100매 채취)에 있어서, 지름 2mm 이상의 불용해 응집물이 발생한 비율로 평가를 행했다. 하기 평가 기준으로 「◎」 또는 「○」를 합격으로 했다.In the sampling during the leading edge of the pressure-sensitive adhesive composition obtained by kneading (100 sheets of 12 g/14 cm x 10 cm formulations were taken) as the insoluble aggregate incidence rate, evaluation was performed at the rate of occurrence of insoluble aggregates having a diameter of 2 mm or more. "◎" or "○" was taken as the pass in the following evaluation criteria.
<판단 기준><Judgment Criteria>
◎: 2% 이하◎: 2% or less
○: 2% 초과 5% 이하○: more than 2% and less than 5%
×: 5% 초과×: more than 5%
[8시간 후의 벗겨짐·말림][Peeling and curling after 8 hours]
건강한 성인 9명의 장딴지에 10cm×14cm로 재단한 첩부제를 붙이고, 8시간 후의 상태를 하기 평점에 의거하여 평가했다. 결과를 9명의 평점 합계점으로부터 하기 평가 기준으로 나타낸다. 27점 이상을 합격으로 했다.A patch cut into 10 cm x 14 cm was applied to the calf of 9 healthy adults, and the condition after 8 hours was evaluated based on the following rating. The results are shown in the following evaluation criteria from the total score of nine people. 27 points or more were taken as pass.
<평점><rating>
5: 첩부제의 벗겨짐·말림 없음5: No peeling or curling of the patch
4: 첩부제의 주위에 벗겨짐·말림 있음(전체의 1/4 미만)4: There is peeling and curling around the patch (less than 1/4 of the whole)
3: 첩부제의 주위에 벗겨짐·말림 있음(전체의 1/4 이상 1/3 미만)3: Peeling and curling around the patch (more than 1/4 to less than 1/3 of the whole)
2: 첩부제의 주위에 벗겨짐·말림 있음(전체의 1/3 이상 1/2 미만)2: Peeling and curling around the patch (more than 1/3 of the whole but less than 1/2)
1: 첩부제의 주위 1/2 이상으로 말림 있음, 또는 벗겨져 떨어졌음1: There is curling more than 1/2 of the circumference of the patch, or peeling off
<8시간 후의 벗겨짐·말림 있음 평가 기준><Evaluation criteria for peeling and curling after 8 hours>
◎: 9명의 평가 결과의 합계점이 36점 이상◎: The total score of the evaluation results of 9 persons is 36 points or more
○: 9명의 평가 결과의 합계점이 27점 이상 36점 미만○: The total score of the evaluation results of 9 persons is 27 points or more and less than 36 points
×: 9명의 평가 결과의 합계점이 27점 미만×: The total score of the evaluation results of 9 persons is less than 27 points
[이면 얼룩][Back stain]
첩부제를 제조 후 20매 겹쳐 쌓고, 만 하루 정치 후, 맨 아래의 첩부제에 대하여 목시 및 관능 평가에 의해 이하의 평가 기준으로 평가했다.Twenty sheets of the patch were stacked after production, and after standing for one day, the bottom patch was evaluated by visual and sensory evaluation according to the following evaluation criteria.
◎: 이면 얼룩은 확인되지 않음 ◎: No stains on the back side
○: 약간의 이면 얼룩이 있지만, 사용할 수 있는 한계 레벨임○: There is some dirt on the back side, but it is a limit level that can be used.
×: 촉촉하게 젖어 있는 것을 확인할 수 있음×: It can be confirmed that it is moist and wet.
[pH][pH]
25℃의 조건 하에서 pH 미터로서 DKK-TOA CORPORATION제의 HM-30V, 플랫형 pH 전극 GST-5313F를 사용하고, 직접 점착제 조성물에 접촉시켜서 측정을 행했다.Measurement was carried out by directly contacting the pressure-sensitive adhesive composition using HM-30V manufactured by DKK-TOA CORPORATION and flat pH electrode GST-5313F as a pH meter under the conditions of 25°C.
실시예 16의 점착제 조성물에 대해서는 마찬가지의 방법으로 평량 90g/㎡의 부직포를 사용하여 첩부제도 조제했다. 얻어진 첩부제에 대하여 상기 실시예와 마찬가지의 방법으로 이면 얼룩을 평가한 결과, 이면 얼룩은 확인되지 않았다. For the pressure-sensitive adhesive composition of Example 16, a patch was also prepared using a nonwoven fabric having a basis weight of 90 g/m 2 in the same manner. As a result of evaluating the back side unevenness of the obtained patch in the same manner as in the above example, no back side unevenness was observed.
비교예 1은 불용해 응집물이 지나치게 많아서 점착제층을 제작할 수 없었기 때문에 「8시간 후의 벗겨짐·말림」 및 [이면 얼룩]의 평가는 하고 있지 않다. In Comparative Example 1, since there were too many insoluble aggregates and the pressure-sensitive adhesive layer could not be produced, evaluation of "peeling and curling after 8 hours" and [backside unevenness] were not performed.
상기 예에서 사용한 원료를 하기에 나타낸다. 또한, 특별히 명기가 없는 한, 표 중의 각 성분의 양은 순분 환산량이다.The raw materials used in the above examples are shown below. In addition, unless otherwise specified, the amounts of each component in the table are in terms of net content.
·폴리아크릴산 부분 중화물: 「ARONVIS AH-106X」(Toagosei Co., Ltd.제), 질량 평균 분자량: 450만(겔 투과 크로마토그래피), 중화도 40mol%, 백색 분체Partially neutralized polyacrylic acid: "ARONVIS AH-106X" (manufactured by Toagosei Co., Ltd.), mass average molecular weight: 4.5 million (gel permeation chromatography), degree of neutralization 40 mol%, white powder
·카르복시메틸셀룰로오스나트륨: 「Daicel CMC1380」(DAICEL FINECHEM LTD.제), 25℃에서의 1% 수용액 점도 1,000~2,000mPa·s(BL 점도계: 로터 No.3 또는 No.4, 25℃·회전수 60rpm), 에테르화도 1.0~1.5, 백색 분체Sodium carboxymethylcellulose: “Daicel CMC1380” (manufactured by DAICEL FINECHEM LTD.), 1% aqueous solution viscosity at 25°C 1,000 to 2,000 mPa·s (BL viscometer: Rotor No.3 or No.4, 25°C·Rotation speed) 60rpm), etherification degree 1.0~1.5, white powder
·카르복시메틸셀룰로오스나트륨: 「Daicel CMC1390」:(DAICEL FINECHEM LTD.제), 25℃에서의 1% 수용액 점도 2,500~4,500mPa·s(BL 점도계: 로터 No.4, 25℃·회전수 60rpm), 에테르화도 1.0~1.5, 백색 분체Sodium carboxymethylcellulose: "Daicel CMC1390": (manufactured by DAICEL FINECHEM LTD.), viscosity of 1% aqueous solution at 25°C 2,500 to 4,500 mPa·s (BL viscometer: Rotor No.4, 25°C, rotation speed 60 rpm), Etherization degree 1.0~1.5, white powder
·카르복시메틸셀룰로오스: 「NS-300」: (Gotoku Chemical Company Ltd.)Carboxymethylcellulose: "NS-300": (Gotoku Chemical Company Ltd.)
·히드록시프로필셀룰로오스: 「HPC-H」: (Nippon Soda Co., Ltd.)Hydroxypropyl cellulose: "HPC-H": (Nippon Soda Co., Ltd.)
·크로스카르멜로오스나트륨: 「KICCOLATE ND-2HS」: (Nichirin Chemical Industries, Ltd.)・Crosscarmellose sodium: 「KICCOLATE ND-2HS」: (Nichirin Chemical Industries, Ltd.)
·글리세린: 농글리세린 「약국방 농글리세린」(Sakamoto Yakuhin kogyo Co., Ltd.제)Glycerin: Strong glycerin "Pharmacy Defense Strong Glycerin" (manufactured by Sakamoto Yakuhin kogyo Co., Ltd.)
·프로필렌글리콜: 「프로필렌글리콜」(미츠이타케다케미컬 가부시키가이샤제)Propylene glycol: "Propylene glycol" (made by Mitsui Takeda Chemical Co., Ltd.)
·디히드록시알루미늄아미노아세테이트: 「GLYCINAL」(Showa Kagaku Kogyo Co., Ltd,)Dihydroxyaluminum amino acetate: 「GLYCINAL」 (Showa Kagaku Kogyo Co., Ltd,)
·합성 히드로탈사이트: 「ALCAMAC SH」(Kyowa Chemical Industry Co., Ltd.제)Synthetic hydrotalcite: "ALCAMAC SH" (manufactured by Kyowa Chemical Industry Co., Ltd.)
·에데트산나트륨 수화물: 「에데트산나트륨」(Chelest Corporation제)・Sodium edetate hydrate: "Sodium edetate" (manufactured by Chelest Corporation)
·메타인산나트륨: 「메타인산나트륨」(Taihei Chemical Industrial Co., Ltd.제)Sodium metaphosphate: “Sodium metaphosphate” (manufactured by Taihei Chemical Industrial Co., Ltd.)
·시트르산: 「시트르산」(Iwata Chemical Co., Ltd.제)Citric acid: "Citric acid" (manufactured by Iwata Chemical Co., Ltd.)
·주석산: 「주석산」 (Iwata Chemical Co., Ltd.제)Tartaric acid: "tartaric acid" (manufactured by Iwata Chemical Co., Ltd.)
·말산: 「말산」( Kyowa Hakko Kogyo Kabushiki Kaisha제)・Malic acid: 「Malic acid」 (manufactured by Kyowa Hakko Kogyo Kabushiki Kaisha)
·락트산: 「락트산」 (Junsei Chemical Co., Ltd.제)-Lactic acid: "lactic acid" (manufactured by Junsei Chemical Co., Ltd.)
·l-멘톨: 「멘톨 JP」(Takasago International Corporation제)-L-menthol: "Menthol JP" (manufactured by Takasago International Corporation)
·록소프로펜나트륨: 「일본약국방 록소프로펜나트륨 수화물」(Daiwa Pharmaceutical Co., Ltd.제) ・Sodium loxoprofen: "Japanese Pharmacopoeia Loxoprofen sodium hydrate" (manufactured by Daiwa Pharmaceutical Co., Ltd.)
·디클로페낙나트륨: 「일본약국방 디클로페낙나트륨」(Daiwa Pharmaceutical Co., Ltd.제)Diclofenac sodium: 「Japanese Pharmacopoeia Diclofenac Sodium」 (manufactured by Daiwa Pharmaceutical Co., Ltd.)
·펠비낙: 「펠비낙」(HANSEO CHEMICAL제)Felvinac: 「Felvinac」 (manufactured by HANSEO CHEMICAL)
·인도메타신: 「인도메타신」(KONGO CHEMICAL CO., LTD.제)Indomethacin: 「Indomethacin」 (manufactured by KONGO CHEMICAL CO., LTD.)
·살리실산글리콜: 「살리멘트」(API Corporation)・Salicylic acid glycol: 「Saliment」 (API Corporation)
·폴리옥시에틸렌(20) 소르비탄 올레산 에스테르: 「NIKKOL TO-10MV」(Nikko Chemicals Co., Ltd.제)Polyoxyethylene (20) sorbitan oleic acid ester: "NIKKOL TO-10MV" (manufactured by Nikko Chemicals Co., Ltd.)
·파라옥시벤조산메틸: 「파라옥시벤조산메틸」(Ueno Fine Chemicals Industry, Ltd.제)Methyl paraoxybenzoate: "Methyl paraoxybenzoate" (manufactured by Ueno Fine Chemicals Industry, Ltd.)
·파라옥시벤조산프로필: 「멧킨스-P」 (Ueno Fine Chemicals Industry, Ltd.제)-Paraoxybenzoic acid propyl: "Mechkins-P" (manufactured by Ueno Fine Chemicals Industry, Ltd.)
·오렌지유: 「ORANGE」(Takasago International Corporation제)Orange oil: 「ORANGE」 (manufactured by Takasago International Corporation)
·레몬유: 「LEMON」(Takasago International Corporation제)Lemon oil: "LEMON" (manufactured by Takasago International Corporation)
·라벤더유: 「LAVENDER EC-3439」(Takasago International Corporation제)Lavender oil: 「LAVENDER EC-3439」 (manufactured by Takasago International Corporation)
·로즈마리유: 「ROSEMARY B LT-8240」(Takasago International Corporation제)Rosemary oil: 「ROSEMARY B LT-8240」 (manufactured by Takasago International Corporation)
·세이지유: 「SAGE M_0020336」(V. Mane Fils Japan, Ltd.제)Sage Yu: ``SAGE M_0020336'' (manufactured by V. Mane Fils Japan, Ltd.)
·적색 404호: 「RED 4」(Kishi Kasei Co., Ltd.제)Red No. 404: 「RED 4」 (manufactured by Kishi Kasei Co., Ltd.)
·지지체: 폴리에스테르제의 편성포 「평량 105±10g/㎡, 두께 0.70mm, 굵기 75데니어 (Teijin Frontier Co., Ltd.제)· Support: Polyester knitted fabric “Basic weight 105±10g/m², thickness 0.70mm, thickness 75 denier (manufactured by Teijin Frontier Co., Ltd.)
·박리 라이너: 폴리프로필렌제의 필름 「CPP30μ, 두께 0.12mm」(OG CORPORATION제)Peeling liner: Polypropylene film "CPP30μ, thickness 0.12mm" (manufactured by OG CORPORATION)
(주석): 「」안은 상품명(Note): ``'' is the product name
Claims (7)
상기 점착제층이,
(A) 폴리아크릴산 및 그 염으로부터 선택되는 1종 이상,
(B) 25℃에서의 1질량% 수용액 점도가 2,000mPa·s 이하인 카르복시메틸셀룰로오스나트륨 및 25℃에서의 1질량% 수용액 점도가 2,500mPa·s 이상인 카르복시메틸셀룰로오스나트륨을 포함하는 셀룰로오스 유도체,
(C) 다가 알코올, 및
(D) 다가 금속염을 함유하는 첩부제.As a patch provided with a pressure-sensitive adhesive layer and a support having a water content of 70% by mass or more,
The pressure-sensitive adhesive layer,
(A) one or more selected from polyacrylic acid and salts thereof,
(B) a cellulose derivative comprising sodium carboxymethylcellulose having a viscosity of 1 mass% aqueous solution at 25°C of 2,000 mPa·s or less and sodium carboxymethyl cellulose having a viscosity of 1 mass% aqueous solution at 25°C of 2,500 mPa·s or more,
(C) polyhydric alcohol, and
(D) A patch containing a polyvalent metal salt.
(A)성분의 함유량이 점착제층 중 2.4~10.0질량%,
(B)성분의 함유량이 점착제층 중 1.5~5.4질량%이며,
식(I): [(A)성분의 함유량]/[(B)성분의 함유량](질량비)가 1.0~6.67이고, 또한
식(II): [(C)성분의 함유량]/{1.5×[(A)성분의 함유량]+2×[(B)성분의 함유량]}(질량비)가 1~3인 첩부제.The method of claim 1,
The content of the component (A) is 2.4 to 10.0 mass% in the pressure-sensitive adhesive layer,
The content of the component (B) is 1.5 to 5.4 mass% in the pressure-sensitive adhesive layer,
Formula (I): [content of (A) component]/[content of (B) component] (mass ratio) is 1.0 to 6.67, and
Formula (II): [content of (C) component]/{1.5 x [content of (A) component] + 2 x [content of (B) component]} (mass ratio) of 1 to 3 patch.
(C)성분의 함유량이 점착제층 중 11~25.2질량%인 첩부제.The method according to claim 1 or 2,
(C) A patch in which the content of the component is 11 to 25.2% by mass in the pressure-sensitive adhesive layer.
(D)성분의 함유량이 점착제층 중 0.01~2질량%인 첩부제.The method according to any one of claims 1 to 3,
(D) A patch in which the content of the component is 0.01 to 2% by mass in the pressure-sensitive adhesive layer.
(E) 유효 성분, 청량화제 및 온감 부여제로부터 선택되는 1종 이상을 더 함유하는 첩부제.The method according to any one of claims 1 to 4,
(E) A patch further containing at least one selected from an active ingredient, a refreshing agent, and a warmth imparting agent.
(A) 폴리아크릴산 및 그 염으로부터 선택되는 1종 이상과, (B) 셀룰로오스 유도체를 (C) 다가 알코올에 분산시키는 공정을 포함하는 첩부제의 제조 방법.As a manufacturing method of the patch according to any one of claims 1 to 5,
(A) at least one selected from polyacrylic acid and its salt, and (B) a method for producing a patch comprising a step of dispersing a cellulose derivative in (C) a polyhydric alcohol.
(A)성분 및 (B)성분이 분체인 첩부제의 제조 방법.
The method of claim 6,
(A) component and (B) component are the manufacturing method of the patch which is powder.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2017-249550 | 2017-12-26 | ||
JP2017249550 | 2017-12-26 | ||
PCT/JP2018/047291 WO2019131524A1 (en) | 2017-12-26 | 2018-12-21 | Adhesive patch and method for producing same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200103618A true KR20200103618A (en) | 2020-09-02 |
KR102636944B1 KR102636944B1 (en) | 2024-02-15 |
Family
ID=67067357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020207000531A KR102636944B1 (en) | 2017-12-26 | 2018-12-21 | Patch and its manufacturing method |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP7147786B2 (en) |
KR (1) | KR102636944B1 (en) |
CN (1) | CN111511356A (en) |
WO (1) | WO2019131524A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001122772A (en) | 1999-10-22 | 2001-05-08 | Lion Corp | Hydrous adhesive composition and cataplasma |
JP2002136587A (en) | 2000-11-02 | 2002-05-14 | Lion Corp | Disperse auxiliary agent and skin external adhesive composition |
JP2014028767A (en) | 2012-07-31 | 2014-02-13 | Lion Corp | Patch |
JP2017008024A (en) * | 2015-06-18 | 2017-01-12 | ライオン株式会社 | Patches |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH107551A (en) * | 1996-06-20 | 1998-01-13 | Dai Ichi Kogyo Seiyaku Co Ltd | Base for cataplasma and cataplasma using the same |
JP2006199607A (en) * | 2005-01-19 | 2006-08-03 | Dai Ichi Kogyo Seiyaku Co Ltd | Water-soluble ointment base agent and ointment obtained using the same |
JP4893124B2 (en) * | 2006-06-27 | 2012-03-07 | ライオン株式会社 | Liquid oral composition |
JP5907075B2 (en) * | 2010-12-27 | 2016-04-20 | ライオン株式会社 | Dentifrice composition |
-
2018
- 2018-12-21 JP JP2019561656A patent/JP7147786B2/en active Active
- 2018-12-21 WO PCT/JP2018/047291 patent/WO2019131524A1/en active Application Filing
- 2018-12-21 KR KR1020207000531A patent/KR102636944B1/en active IP Right Grant
- 2018-12-21 CN CN201880083439.1A patent/CN111511356A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001122772A (en) | 1999-10-22 | 2001-05-08 | Lion Corp | Hydrous adhesive composition and cataplasma |
JP2002136587A (en) | 2000-11-02 | 2002-05-14 | Lion Corp | Disperse auxiliary agent and skin external adhesive composition |
JP2014028767A (en) | 2012-07-31 | 2014-02-13 | Lion Corp | Patch |
JP2017008024A (en) * | 2015-06-18 | 2017-01-12 | ライオン株式会社 | Patches |
Also Published As
Publication number | Publication date |
---|---|
WO2019131524A1 (en) | 2019-07-04 |
JP7147786B2 (en) | 2022-10-05 |
CN111511356A (en) | 2020-08-07 |
KR102636944B1 (en) | 2024-02-15 |
JPWO2019131524A1 (en) | 2020-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI625131B (en) | Paste and method for making same | |
KR101015491B1 (en) | Patch | |
US20040156886A1 (en) | Sheet-like patch agent | |
TW200948402A (en) | Composition for external use on skin | |
KR20080015120A (en) | Skin patch | |
TWI672154B (en) | Gel patch | |
JP7098181B2 (en) | Adhesive sheet for skin application and transdermal pharmaceutical product using it | |
JP2017154989A (en) | S/o type patch | |
JP2018172420A (en) | Adhesive sheet for skin patch, and percutaneous absorption preparation using the same | |
CN104394858B (en) | Percutaneous absorption promoter and skin patch comprising same | |
KR20090085064A (en) | Adhesive skin patch and method for evaluation of adhesive skin patch | |
JP2007186499A (en) | Bisoprolol-containing adhesive preparation | |
CN101669924B (en) | Patch and patch preparation | |
JP2022075038A (en) | Patch and method for suppressing precipitation of menthol | |
KR102636944B1 (en) | Patch and its manufacturing method | |
JP4786196B2 (en) | Gel composition and method for producing the same | |
JP2001026540A (en) | Indomethacin plaster | |
JP2001122772A (en) | Hydrous adhesive composition and cataplasma | |
JP5085062B2 (en) | Transdermal patch | |
JP5949285B2 (en) | Patch | |
JP4519408B2 (en) | Patch composition and production method thereof | |
TW201139605A (en) | Hydrous adhesive patch | |
JPH0555485B2 (en) | ||
JPH06135828A (en) | Percutaneous absorption preparation | |
JP2008239497A (en) | Antiphlogistic-sedative plaster |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |